CN1939433A - Quality control of Chinese medicinal compound preparation - Google Patents

Quality control of Chinese medicinal compound preparation Download PDF

Info

Publication number
CN1939433A
CN1939433A CN 200510107818 CN200510107818A CN1939433A CN 1939433 A CN1939433 A CN 1939433A CN 200510107818 CN200510107818 CN 200510107818 CN 200510107818 A CN200510107818 A CN 200510107818A CN 1939433 A CN1939433 A CN 1939433A
Authority
CN
China
Prior art keywords
solution
ginsenoside
chinese medicinal
methanol
compound chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510107818
Other languages
Chinese (zh)
Inventor
于文风
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qiyuanyide Medicines Institute Beijing
Original Assignee
Qiyuanyide Medicines Institute Beijing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiyuanyide Medicines Institute Beijing filed Critical Qiyuanyide Medicines Institute Beijing
Priority to CN 200510107818 priority Critical patent/CN1939433A/en
Publication of CN1939433A publication Critical patent/CN1939433A/en
Pending legal-status Critical Current

Links

Landscapes

  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

A quality control method for the Chinese medicine prepared from ginseng (or red ginseng or pilose asiabell root) and white peony root (or red peony root) includes the fingerprint test method and/or differentiation test method and/or content measuring method.

Description

A kind of method of quality control of compound Chinese medicinal preparation
Technical field
The present invention is a kind of method of quality control of compound Chinese medicinal preparation, belongs to technical field of Chinese medicine.
Background technology
Cardiovascular and cerebrovascular disease such as coronary heart disease, cerebral thrombosis, alzheimer disease etc. all are one of diseases that the world today is the most common and harm is maximum, have become human mortality's one of the main reasons in many countries; According to investigations, sickness rate in recent years has and increases trend year by year, and in, young patient constantly increases, ischemic cardiovascular and cerebral vascular disease has become commonly encountered diseases, the frequently-occurring disease of harm China people ' s health; Prevent and treat purpose in order to reach, number of research projects has been done to it by many inventors and medicine enterprise.Pharmaceutical preparation must be on the basis that guarantees the constant product quality controllable safety, constantly more new development, in order better to control the quality of said preparation, guarantee the safety of medication, better instruct and produce, make technology controlling and process rationally strict more, make consumer's energy full appreciation product quality, need research, control this compound Chinese medicinal preparation method for quality; At present, in the related drugs preparation, generally only with the ginsenoside Rg 1, ginsenoside Rb 1, ginsenoside Re, peoniflorin be for detecting index, but its quality of reactor product comprehensively at all is not very reasonable with this quality that is used for controlling compound Chinese medicinal preparation only; If control,, relatively be difficult to implement owing to do not have ready-made detection scheme, testing conditions or the like with other index.
Summary of the invention
The object of the present invention is to provide a kind of method of quality control of new compound Chinese medicinal preparation.This method provides means, technical method of the index that detects, detection or the like to relevant production, testing agency, so that better control the quality of said preparation, guarantee the safety of medication, can better instruct production, make controlling of production process rationally strict more, make consumer's energy full appreciation product quality.
The flavour of a drug of this compound Chinese medicinal preparation are formed and proportioning following (by weight):
Scheme one:
Radix Ginseng (or Radix Ginseng Rubra or Radix Codonopsis) 1~99 weight portion Radix Paeoniae Rubra (or Radix Paeoniae Alba) 99~1 weight portions
Scheme two:
Radix Ginseng (or Radix Ginseng Rubra or Radix Codonopsis) extract 0.1~20 weight portion Radix Paeoniae Rubra (or Radix Paeoniae Alba) 99~1 weight portions
Scheme three:
Radix Ginseng (or Radix Ginseng Rubra or Radix Codonopsis) 1~99 weight portion Radix Paeoniae Rubra (or Radix Paeoniae Alba) 30~0.1 weight portions
Scheme four:
Radix Ginseng (or Radix Ginseng Rubra or Radix Codonopsis) extract 0.1~20 weight portion Radix Paeoniae Rubra (or Radix Paeoniae Alba) 30~0.1 weight portions
The dosage form of above-mentioned compound Chinese medicinal preparation is injection or oral formulations; Wherein injection comprises: be directly used in the injection of drug administration by injection, directly for the venous transfusion of intravenous drip, need to be used for after the dilution concentrated solution for injection of intravenous drip and with the injectable sterile powder or the aseptic block of freeze-drying or spray drying method for preparation; Oral formulations comprises tablet, dispersible tablet, capsule, soft capsule, microcapsule, granule, pill, pellet, powder, drop pill, slow releasing preparation, controlled release preparation, oral liquid, gel, soft extract, extractum and membrane.Be used for the treatment of diseases such as coronary heart disease, angina pectoris, arrhythmia, cerebral thrombosis, alzheimer disease, hepatorenal syndrome, heart and lung diseases, diabetes and complication thereof clinically.
The present invention constitutes like this:
The method of quality control of the compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba, it is characterized in that: this method comprises following all or part of content:
(1) finger printing of compound Chinese medicinal preparation test, comprise with Radix Ginseng Rubra or constituent of ginseng be characterized as main finger printing, based on the finger printing of Radix Codonopsis composition characteristics with based in the finger printing of Radix Paeoniae Rubra or Radix Paeoniae Alba composition characteristics one or more;
(2) Radix Ginseng Rubra or ginseng crude drug, Radix Paeoniae Rubra or white Peony Root, ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, the differential test method of all or part of composition among the ginsenoside Re, ginsenoside Rf, peoniflorin, gallic acid, lobetyolin, atractylenoide;
(3) ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, ginsenoside Re, peoniflorin, Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides, total polysaccharides, total saponins, lobetyolin, all or part of composition of atractylenoide content test method.
The method of quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba is characterized in that: with Radix Ginseng Rubra or constituent of ginseng be characterized as main finger printing, based on the finger printing of Radix Codonopsis composition characteristics with based in the finger printing of Radix Paeoniae Rubra or Radix Paeoniae Alba composition characteristics one or more:
A, employing liquid chromatography test Radix Ginseng Rubra or constituent of ginseng are characterized as main finger printing:
(1) preparation of need testing solution: it is an amount of to get compound Chinese medicinal preparation to be measured, adds water or methanol or dissolve with ethanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active reference substance in an amount of Radix Ginseng Rubra or Radix Ginseng and the Radix Ophiopogonis medical material, comprise the ginsenoside Rg 1, ginsenoside Rb 1, a kind of among the ginsenoside Re, ginsenoside Rf, water or methanol or dissolve with ethanol are settled to suitable concn, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase A is 0.01mol/L~2mol/L sodium dihydrogen phosphate or 0.01mol/L~2mol/L potassium dihydrogen phosphate or water or 0.1%~5% glacial acetic acid solution or 0.1%~5% formic acid solution or 0.02%~5% phosphoric acid solution; B is 10%~90% acetonitrile solution or 10%~90% methanol solution, and gradient elution, flow velocity be 0.5~2.0ml/min, detect wavelength is that one or several or evaporation photodetector in 190~410nm scope detects, and column temperature is in 20~60 ℃ of scopes;
(4) formulation of standard finger-print: the means of testing that is characterized as main standard finger-print with said method as formulation with Radix Ginseng Rubra or constituent of ginseng; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, in the described standard finger-print, total peak has 5~30, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, its relative standard deviation must not surpass ± 20%;
(5) be characterized as the means of testing of main finger printing with the described method in (1)~(3) as Radix Ginseng Rubra or constituent of ginseng in the compound Chinese medicinal preparation to be measured, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.80~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 10% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 20%;
B, employing liquid chromatography are tested the finger printing based on the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics:
(1) preparation of need testing solution: it is an amount of to get compound Chinese medicinal preparation to be measured, adds water or methanol or dissolve with ethanol or dilution, shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get peoniflorin,, be settled to suitable concn, as object of reference solution with methanol or dissolve with ethanol;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is 0.5%~100% acetonitrile solution or methanol: 0.005mol/L~5mol/L sodium dihydrogen phosphate or 0.005mol/L~5mol/L potassium dihydrogen phosphate or 0.1%~5% glacial acetic acid or 0.1%~5% formic acid or 0.005%~5% phosphoric acid solution, gradient elution, flow velocity is that 0.5~2.0ml/min, detection wavelength are one or several in the 190-400nm scope, and column temperature is in 20~60 ℃ of scopes;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulating standard finger-print, is benchmark with the retention time of the object of reference chromatographic peak determined, calculates the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~30;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.80~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 10% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 20%;
C, employing liquid chromatography test Radix Codonopsis composition characteristics are main finger printing:
(1) preparation of need testing solution: it is an amount of to get compound Chinese medicinal preparation to be measured, adds water or methanol or dissolve with ethanol or dilution, shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active reference substance in an amount of codonopsis pilosula, comprise in lobetyolin, the atractylenoide one or both, water or methanol, dissolve with ethanol are diluted to suitable concn, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is 5%~99%: 95%~5% acetonitrile or methanol-water or 0.01mol/L~2mol/L sodium dihydrogen phosphate or 0.2%~3% glacial acetic acid or 0.2%~3% formic acid or 0.2%~3% phosphoric acid solution, flow velocity is 0.5~2.0ml/min, detect wavelength is that one or several or evaporation photodetector in the 190-300nm scope detects, and column temperature is in 20~60 ℃ of scopes;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the finger printing of Radix Codonopsis composition characteristics; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulating standard finger-print, is benchmark with the retention time of the object of reference chromatographic peak determined, calculates the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~30;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of Radix Codonopsis composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.80~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 10% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 20%.
The method of quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba is characterized in that: this method adopts liquid chromatography test to be characterized as main finger printing with Radix Ginseng Rubra or constituent of ginseng and based on the finger printing of Radix Paeoniae Rubra or Radix Paeoniae Alba composition characteristics:
A, employing liquid chromatography for measuring are characterized as main finger printing with Radix Ginseng Rubra or constituent of ginseng:
(1) preparation of need testing solution: it is an amount of that precision takes by weighing compound Chinese medicinal preparation to be measured, adds water and make the solution that every 1ml contains 50mg, with the microporous filter membrane filtration of 0.45 μ m, gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: precision takes by weighing the ginsenoside Rg 1In right amount, add methanol and make the solution that every 1ml contains 0.3mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler; Mobile phase A is the 0.05mol/L potassium dihydrogen phosphate, and Mobile phase B is acetonitrile-water 80: 20, gradient elution, solvent ratios is from 0 minute to 5 minutes, the ratio of Mobile phase B is 25%, and from 5 minutes to 40 minutes, the ratio of Mobile phase B rose to 64% by 25%, from 40 minutes to 50 minutes, the ratio of Mobile phase B is 64%, and from 50 minutes to 65 minutes, the ratio of Mobile phase B rose to 80% by 64%, from 65 minutes to 75 minutes, the ratio of Mobile phase B reduced to 25% by 80%; Flow velocity is 1.0ml/min, and the detection wavelength is 203 ± 2nm, and column temperature is 40 ℃;
(4) formulation of standard finger-print: the means of testing that is characterized as main standard finger-print with said method as formulation with Radix Ginseng Rubra or constituent of ginseng; Accurate object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, total peak has 5~20, retention time with definite object of reference chromatographic peak is a benchmark, calculates the relative retention time of other total chromatographic peak, and its relative standard deviation must not surpass ± 10%;
(5) be characterized as the means of testing of main finger printing with the described method in (1)~(3) as Radix Ginseng Rubra or constituent of ginseng in the compound Chinese medicinal preparation to be measured, the finger printing of preparation testing sample;
(6) with the contrast of compound Chinese medicinal preparation finger printing to be measured and above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.90~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 5% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 10%;
B, adopt the finger printing of liquid chromatography for measuring based on the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics:
(1) preparation of need testing solution: it is an amount of that precision takes by weighing compound Chinese medicinal preparation to be measured, adds water and make the solution that every 1ml contains 1mg, shakes up, promptly;
(2) preparation of object of reference solution: it is an amount of that precision takes by weighing peoniflorin, adds methanol and make the solution that every 1ml contains 0.15mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler; Mobile phase A is 80% acetonitrile, and Mobile phase B is 0.1% phosphoric acid solution, gradient elution, and solvent ratios was from 0 minute to 80 minutes, and the ratio of mobile phase A rises to 70% by 15%, and the ratio of Mobile phase B rises to 30% by 85%; Flow velocity is 1.0ml/min, and the detection wavelength is 230 ± 2nm, and column temperature is 40 ℃;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the standard finger-print of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics; Accurate respectively object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~20;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.90~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 5% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 10%;
C, employing liquid chromatography test Radix Codonopsis composition characteristics are main finger printing:
(1) preparation of need testing solution: it is an amount of that precision takes by weighing compound Chinese medicinal preparation to be measured, adds methanol and make the solution that every 1ml contains 50mg, filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active atractylenoide in an amount of codonopsis pilosula, add methanol and make the solution that every 1ml contains 0.1mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is methanol-water 67: 33, and flow velocity is that 1.0ml/min, evaporation photodetector detect, 30 ℃ of drift tube temperatures, and carrier gas flux 2.2L/min, column temperature are 30 ℃;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the standard finger-print of Radix Codonopsis composition characteristics; Accurate respectively object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~20;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of Radix Codonopsis composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.90~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 5% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 10%.
The method of quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba, it is characterized in that: the discrimination method of described compound Chinese medicinal preparation comprises following all or part of content:
Radix Ginseng Rubra or Radix Ginseng, ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more thin layer chromatography discrimination method among the ginsenoside Re, ginsenoside Rf:
It is an amount of to get compound Chinese medicinal preparation to be measured, with n-butyl alcohol or ethanol or methanol or ethyl acetate or chloroform extraction, filters, and filtrate is as need testing solution; Other gets Radix Ginseng Rubra or Radix Ginseng control medicinal material, ginsenoside Rg 1, ginsenoside Rb 1, among the ginsenoside Re, ginsenoside Rf one or more, the preparation contrast solution; The preparation of Radix Ginseng Rubra or Radix Ginseng control medicinal material solution: get Radix Ginseng Rubra or the Radix Ginseng control medicinal material is an amount of, add the chloroform reflux, extract,, discard chloroform liquid, residue adds water-saturated n-butanol or ethyl acetate extraction, extracting solution adds ammonia solution, divides and gets upper strata, evaporate to dryness, residue is with methanol or dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re, ginsenoside Rf, add methanol or ethanol respectively and make the solution that every 1ml contains 2mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 1~30 μ l of above-mentioned solution, put respectively in same silica gel g thin-layer plate or silica gel H lamellae or silica gel G F 254On the lamellae, lower floor's solution or n-butyl alcohol-ethyl acetate or the Ethyl formate-water 1~10: 0.2~2 placed below 5~40: 10~100: 5~50: 0.2~30 10 ℃ with chloroform-ethyl acetate or Ethyl formate-methanol-water: 1~15 upper strata is developing solvent, launch, take out, dry, spray is with 5~50% sulphuric acid ethanol reagent or 50% sulphate reagent, 80 ℃~160 ℃ dry by the fire to speckle colour developing clear, put respectively under daylight and the ultra-violet lamp 365nm and inspect, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, should show the speckle of same color, negative noiseless;
Ginsenoside Rg in b, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more liquid chromatograph is differentiated among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds water or methanol or mobile phase or ethanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1The methanol of one or more reference substances among the ginsenoside Re or alcoholic solution are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, 5%~40%: 95%~60% methanol or acetonitrile-water or 0.5%~5% glacial acetic acid aqueous solution or 0.02%~5% phosphate aqueous solution or 0.5%~5% formic acid solution are mobile phase, gradient elution, flow velocity is 0.5~2.0ml/min, one or several or the evaporation photodetector that detect wavelength and be in 190~410nm scope detect, and column temperature is in 20~60 ℃ of scopes; In the test sample chromatograph, answer tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end, negative noiseless.
One or more thin layer chromatography discrimination method in Radix Paeoniae Rubra or white Peony Root, peoniflorin, the gallic acid in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds ethyl acetate or ethanol or methanol or n-butanol extraction, and filtration or centrifugal is got filtrate or supernatant as need testing solution; Other gets one or more preparation contrast solutions in Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, peoniflorin reference substance, the gallic acid reference substance; The preparation of Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution: get Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, add ethyl acetate or ethanol or methanol or n-butanol extraction, filter, filtrate volatilizes, and residue is with methanol or dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get one or both of peoniflorin reference substance, gallic acid reference substance, respectively or merge and add methanol or ethanol is made the solution that every 1ml contains 0.2~5mg; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw one or more each 1~30 μ l of above-mentioned need testing solution and Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution, peoniflorin reference substance solution, gallic acid reference substance solution, peoniflorin gallic acid mixing reference substance solution, put respectively in same silica gel g thin-layer plate or silica gel H lamellae or silica gel G F 254Lamellae, with lower floor's solution of chloroform or dichloromethane-ethyl acetate or Ethyl formate-methanol or ethanol-formic acid or acetic acid 1~120: 0.2~15: 0.5~25: 0.01~5 or chloroform or dichloromethane-ethyl acetate or Ethyl formate-methanol or alcohol-water 3~50: 10~120: 5~60: 1~25 or chloroform or n-butyl alcohol or dichloromethane or toluene-methanol or glacial acetic acid or formic acid-ethyl acetate or water 1~80: 0.1~50: 0.05~25 or chloroform-methanol 1~25: 0.2~15 is developing solvent, launch, take out, dry, spray is with 0.2%~10% ferric chloride alcoholic solution earlier, in the test sample chromatograph, with control medicinal material chromatograph or the corresponding position of reference substance chromatograph on, should show the same color speckle; Spray again with behind the vanillin sulfuric acid solution 80 ℃~160 ℃ dry by the fire to speckle colour developing clear or hot blast blow clear or put under ultra-violet lamp 365nm or the 254nm and inspect to the speckle colour developing, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, should show the same color speckle;
The liquid chromatograph discrimination method of peoniflorin in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds methanol or ethanol or mobile phase or water dissolution or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol or alcoholic solution with the peoniflorin reference substance are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, 5%~95%: 95%~5% methanol or acetonitrile-water or 0.05%~10% glacial acetic acid aqueous solution or 0.05%~10% aqueous formic acid or 0.01%~5% phosphate aqueous solution or 0.005mol/L~2mol/L sodium dihydrogen phosphate or 0.005mol/L~2mol/L potassium dihydrogen phosphate is a mobile phase, and the detection wavelength is 200~410nm; In the test sample chromatograph, answer tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
The thin layer chromatography discrimination method of lobetyolin in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, be dissolved in water, with n-butyl alcohol or ethyl acetate or chloroform extraction, extract is concentrated into dried, and residue is with methanol or dissolve with ethanol, as need testing solution, or put in C18 or the C8 solid phase extraction column, use 5%~50% methanol, methanol-eluted fractions successively, collect meoh eluate, be concentrated into 1ml, as need testing solution; Other gets one or both preparation contrast solutions in Radix Codonopsis control medicinal material, the lobetyolin; The preparation of control medicinal material solution: get the Radix Codonopsis control medicinal material, filter after adding water or methanol extraction, filtrate evaporate to dryness, residue with water dissolution after with n-butyl alcohol or ethyl acetate or chloroform extraction, extract is concentrated into dried, residue is with methanol or dissolve with ethanol, and as need testing solution, or filtrate is put in C18 or the C8 solid phase extraction column, use 5%~50% methanol, methanol-eluted fractions successively, collect meoh eluate, be concentrated into 1ml, as need testing solution; The preparation of reference substance solution: get lobetyolin's reference substance, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 1~30 μ l of above-mentioned solution, put respectively in same silica gel g thin-layer plate or silica gel H lamellae or silica GF254 lamellae, n-butyl alcohol-glacial acetic acid or formic acid or ethanol or dehydrated alcohol-water 1~35: 0.1~10: 0.05~5 are developing solvent, launch, and take out, dry, spray is with 3%~30% ethanol solution of sulfuric acid, and 80~150 ℃ were heated 1~30 minute, and put under the ultra-violet lamp 365nm and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, should show the fluorescence speckle of same color;
The liquid chromatograph discrimination method of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get medicine group to be measured and thing, puts in the measuring bottle, adds methanol or ethanol or mobile phase to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, 5%~80%: 95%~20% methanol or acetonitrile-water or 0.05%~5% glacial acetic acid aqueous solution or 0.02%~0.5% phosphate aqueous solution are mobile phase, the detection wavelength is one or several in 200~410nm scope, in 20~50 ℃ of scopes of column temperature; In the test sample chromatograph, answer tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
The method of quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba, it is characterized in that: the discrimination method of described compound Chinese medicinal preparation comprises following all or part of content:
Radix Ginseng Rubra or Radix Ginseng, ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more thin layer chromatography discrimination method among the ginsenoside Re, ginsenoside Rf:
It is an amount of to get compound Chinese medicinal preparation to be measured, uses n-butanol extraction, filters, and filtrate is as need testing solution; Other gets Radix Ginseng Rubra or Radix Ginseng control medicinal material, ginsenoside Rg 1, ginsenoside Rb 1, among the ginsenoside Re, ginsenoside Rf one or more, preparation control medicinal material solution; The preparation of Radix Ginseng Rubra or Radix Ginseng control medicinal material solution: get Radix Ginseng Rubra or the Radix Ginseng control medicinal material is an amount of, add the chloroform reflux, extract,, discard chloroform liquid, residue adds water-saturated n-butanol and extracts, and extracting solution adds ammonia solution, divides and gets the upper strata, evaporate to dryness, residue dissolve with methanol, medical material solution in contrast; The preparation of reference substance solution: get the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re, ginsenoside Rf, add methanol respectively and make the solution that every 1ml contains 2mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 5 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-water 15: 40: 22: 10 was developing solvent at lower floor's solution of placing below 10 ℃, launch, take out, dry, spray is with 10% sulphuric acid ethanol reagent, and 105 ℃ are dried by the fire to the speckle colour developing clearly, put respectively under daylight and the ultra-violet lamp 365nm and inspect, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the speckle of same color, negative noiseless;
Ginsenoside Rg in b, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more liquid chromatograph is differentiated among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re methanol solution be contrast, adopt liquid chromatography, the chromatographic column octadecylsilane chemically bonded silica is a filler, acetonitrile-water is a mobile phase, gradient elution, solvent ratios are from 0 minute to 35 minutes, and the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29%, from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% by 29%; Flow velocity is 1.0ml/min, detects wavelength 203nm, and column temperature is at 30 ℃; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end, negative noiseless.
One or more thin layer chromatography discrimination method in Radix Paeoniae Rubra or white Peony Root, peoniflorin, the gallic acid in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds methanol extraction, centrifugal, gets supernatant as need testing solution; Other gets one or more preparation contrast solutions in Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, peoniflorin, the gallic acid; The preparation of Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution: get Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, add ethanol extraction, filter, filtrate volatilizes, residue dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get peoniflorin, gallic acid reference substance, add methanol respectively and make the solution that every 1ml contains peoniflorin 2mg, gallic acid 0.5mg respectively; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 5 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-formic acid 6: 1.5: 1.5: 0.5 was developing solvent, launches, take out, dry, spray is with 5% ferric chloride alcoholic solution, in the test sample chromatograph earlier, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the same color speckle; Spray again with behind the vanillin sulfuric acid solution 105 ℃ dry by the fire to speckle colour developing clear or, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the same color speckle;
The liquid chromatograph discrimination method of peoniflorin in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds dissolve with methanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and methanol-0.1% formic acid solution was a mobile phase in 40%: 60%, and the detection wavelength is 230nm; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end;
The thin layer chromatography discrimination method of lobetyolin in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, add methanol 25ml, supersound process 30 minutes filters, the filtrate evaporate to dryness, residue adds water 2ml makes dissolving, puts in the C18 solid phase extraction column (500mg is with methanol, each the 10ml prewashing of 20% methanol), use 20% methanol, each 5ml eluting of methanol successively, collect meoh eluate, be concentrated into 1ml, as need testing solution; Other gets the Radix Codonopsis control medicinal material, shines medical material solution in pairs with legal system; It is an amount of to get lobetyolin's reference substance again, adds methanol and makes every 1ml and contain 1mg solution, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw need testing solution 6 μ l, reference substance solution 2 μ l, put respectively on same high-efficient silica gel G lamellae, with n-butyl alcohol-glacial acetic acid-water is developing solvent at 7: 1: 0.5, launches, and takes out, dry, spray is with 10% ethanol solution of sulfuric acid, and 105 ℃ were heated 5 minutes, and put under the ultra-violet lamp 365nm and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color;
The liquid chromatograph discrimination method of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and acetonitrile-water is a mobile phase at 22: 78, and the detection wavelength is 267nm, 30 ℃ of column temperatures; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
The method of quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba, it is characterized in that: the method for testing of described compound Chinese medicinal preparation content should comprise following all or part of content:
Ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more assay among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds water or methanol or mobile phase or ethanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1The methanol of one or more reference substances among the ginsenoside Re or alcoholic solution are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, 5%~40%: 95%~60% methanol or acetonitrile-water or 0.5%~5% glacial acetic acid aqueous solution or 0.02%~5% phosphate aqueous solution or 0.5%~5% formic acid solution are mobile phase, gradient elution, flow velocity is 0.5~2.0ml/min, one or several or the evaporation photodetector that detect wavelength and be in 190~410nm scope detect, and column temperature is in 20~60 ℃ of scopes; Calculate with one point external standard method or standard curve method, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and content limit should be with the next item down or several:
(1) the per unit amount contains the ginsenoside Rg 1Limit must not be less than 0.8mg;
(2) the per unit amount limit that contains the ginsenoside Re must not be less than 0.4mg;
(3) the per unit amount contains ginsenoside Rb 1Limit must not be less than 0.5mg;
(4) the per unit amount contains the ginsenoside Rg 1, the ginsenoside Re the limit of summation must not be less than 1.7mg;
The assay of total saponins in b, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, and adding distil water makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the measuring bottle, water bath method takes out immediately, and precision adds 1%~50% vanillin-glacial acetic acid solution 0.1~10ml, perchloric acid 0.1~15ml shakes up, and heats 3~50 minutes in 30~80 ℃ of water-baths, take out, with ice-water bath or flowing water cooling, precision adds glacial acetic acid to scale immediately, shake up, as need testing solution, with the ginsenoside Rg 1Or ginsenoside Rb 1Or ginsenoside Re or ginsenoside Rf be reference substance, gets reference substance solution with legal system.With the retinue solvent is blank, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place at 547 ± 10nm measures trap, calculate with external standard method or standard curve method, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and the per unit amount contains total saponins with the ginsenoside Rg 1Or ginsenoside Rb 1Or ginsenoside Re or ginsenoside Rf's meter, must not be less than 3mg;
Total polysaccharides assay in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, and it is an amount of to add 60%~dehydrated alcohol, and supersound process makes molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and is diluted to suitable concn, shakes up, precision is measured in right amount, to tool plug test tube, adding distil water is an amount of, and it is an amount of that precision adds 1%~10% phenol solution, mixing, it is an amount of to add rapidly sulphuric acid, shakes up 30 ℃~60 ℃ water-baths 5~60 minutes, take out, with ice-water bath cooling 1~30 minute, taking out immediately, is blank with the retinue solvent, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place in 488nm ± 10 measures trap, calculates with one point external standard method or standard curve method, and compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, the per unit amount contains total polysaccharides in anhydrous glucose, must not be less than 1.6mg.
Content of paeoniflorin is measured in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds methanol or ethanol or mobile phase or water dissolution or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol or alcoholic solution with the peoniflorin reference substance are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, 5%~95%: 95%~5% methanol or acetonitrile-water or 0.05%~10% glacial acetic acid aqueous solution or 0.05%~10% aqueous formic acid or 0.01%~5% phosphate aqueous solution or 0.005mol/L~2mol/L sodium dihydrogen phosphate or 0.005mol/L~2mol/L potassium dihydrogen phosphate is a mobile phase, and the detection wavelength is 200~410nm; Calculate with one point external standard method or standard curve method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains peoniflorin must not be less than 10mg;
The assay of Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds 1%~50% sodium hydroxide and makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the tool plug test tube, put the boiling water bath hydrolysis 0.5 hour~5 hours, and took out, put to room temperature, quantitatively be transferred in the measuring bottle, swing repeatedly with methanol or mobile phase and to wash test tube wall, fixed to scale, shake up, filter with microporous filter membrane, get subsequent filtrate as need testing solution; Methanol or alcoholic solution with the benzoic acid reference substance are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, 5%~95%: 95%~5% methanol or acetonitrile-water or 0.05%~10% glacial acetic acid aqueous solution or 0.05%~10% aqueous formic acid or 0.01%~5% phosphate aqueous solution or 0.005mol/L~2mol/L sodium dihydrogen phosphate or 0.005mol/L~2mol/L potassium dihydrogen phosphate is a mobile phase, the detection wavelength is one or several in 200~410nm wave-length coverage, and column temperature is in 20~60 ℃ of scopes; Calculate behind the content again by formula Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides content %=benzoic acid content % * 480.48/122.13 with one point external standard method or standard curve method, calculate the content of Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides must not be less than 15mg;
The assay of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, 5%~80%: 95%~20% methanol or acetonitrile-water or 0.05%~5% glacial acetic acid aqueous solution or 0.02%~0.5% phosphate aqueous solution are mobile phase, the detection wavelength is one or several in 200~410nm scope, in 20~50 ℃ of scopes of column temperature; Calculate with one point external standard method or standard curve method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains lobetyolin must not be less than 0.05mg.
The method of quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba, it is characterized in that: the method for testing of described compound Chinese medicinal preparation content is following one or more methods:
Ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more assay among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re methanol solution be contrast, adopt liquid chromatography, the chromatographic column octadecylsilane chemically bonded silica is a filler, acetonitrile-water is a mobile phase, gradient elution, solvent ratios are from 0 minute to 35 minutes, and the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29%, from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% by 29%; Flow velocity is 1.0ml/min, detects wavelength 203nm, and column temperature is 30 ℃; Calculate with external standard method or standard curve method, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and content limit should be with the next item down or several:
(1) the per unit amount contains the ginsenoside Rg 1Limit must not be less than 1.6mg;
(2) the per unit amount limit that contains the ginsenoside Re must not be less than 0.8mg;
(3) the per unit amount contains ginsenoside Rb 1Limit must not be less than 1.0mg;
(4) the per unit amount contains the ginsenoside Rg 1, the ginsenoside Re the limit of summation must not be less than 3.4mg;
The assay of total saponins in b, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the 10ml measuring bottle, adds water to scale, shake up, precision is measured 0.6ml, to the 25ml measuring bottle, water bath method takes out immediately, and precision adds 5% vanillin-glacial acetic acid solution 0.5ml, perchloric acid 2.0ml shakes up, and heating is 15 minutes in 60 ℃ of water-baths, take out, with ice-water bath cooling 2 minutes, precision added glacial acetic acid to 25ml immediately, shake up, as need testing solution; With the ginsenoside Rg 1Be reference substance, get reference substance solution with legal system.With the retinue solvent is blank, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, measure trap, calculate with external standard method or standard curve method at the wavelength place of 547nm, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and the per unit amount contains total saponins with the ginsenoside Rg 1Meter must not be less than 6mg;
The assay of total polysaccharides in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds 80% ethanol 20ml, and supersound process makes molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and is diluted to suitable concn, shakes up, precision is measured in right amount, to 10ml tool plug test tube, adding distil water is to 2ml, and precision adds 4% phenol solution 1ml, mixing, add rapidly sulphuric acid 7ml, shake up, 40 ℃ of water-baths 30 minutes, take out, with ice-water bath cooling 5 minutes, taking out immediately, is blank with the retinue solvent, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place at 488nm measures trap, calculates with one point external standard method or standard curve method, and compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, the per unit amount contains total polysaccharides in anhydrous glucose, must not be less than 3.2mg;
Content of paeoniflorin is measured in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds dissolve with methanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and methanol-0.1% formic acid solution was a mobile phase in 40%: 60%, and the detection wavelength is 230nm; Calculate with one point external standard method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains peoniflorin must not be less than 20mg;
The assay of Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds 5% sodium hydroxide solution and makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the tool plug test tube, put the boiling water bath hydrolysis 2 hours, and took out, put to room temperature, quantitatively be transferred in the 10ml measuring bottle, swing repeatedly with methanol or mobile phase and to wash test tube wall, fixed to scale, shake up, filter with microporous filter membrane, get subsequent filtrate as need testing solution; Methanol solution with the benzoic acid reference substance is contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, acetonitrile-0.02mol/L sodium dihydrogen phosphate was a mobile phase in 20%: 80%, the detection wavelength is 230nm, 35 ℃ of column temperatures; Calculate behind the content again by formula Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides content %=benzoic acid content % * 480.48/122.13 with one point external standard method, calculate the content of Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides must not be less than 30mg;
The assay of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and acetonitrile-water is a mobile phase at 22: 78, and the detection wavelength is 267nm, 30 ℃ of column temperatures; Calculate with one point external standard method or standard curve method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains lobetyolin must not be less than 0.1mg.
The method of quality control of described compound Chinese medicinal preparation is characterized in that: the assay result of described ejection preparation, can survey composition except that adjuvant, the ginsenoside Rg in its quality standard 1, ginsenoside Rb 1, all or part of kind in ginsenoside Re, peoniflorin, Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides, total polysaccharides, total saponins, lobetyolin, atractylenoide etc. total content account for more than 25%.
Compared with prior art, the present invention's quality of the compound Chinese medicinal preparation made with Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba of perfect control more.The Chinese medicine ingredients complexity, if only with wherein one, two kind of composition illustrate its inherent quality, has certain one-sidedness, more can't judge the index components of its drug effect.Therefore the applicant formulated with Radix Ginseng Rubra or constituent of ginseng be characterized as main finger printing, based on the finger printing of Radix Codonopsis composition characteristics with control the quality of compound Chinese medicinal preparation based on finger printing, discriminating and the assay of Radix Paeoniae Rubra or Radix Paeoniae Alba composition characteristics comprehensively.But because contained complex chemical composition between each medical material in the compound Chinese medicinal preparation, formulation, discriminating and assay to finger printing cause interference, cause discriminating, assay and each several part finger printing feature instability, so must control mobile phase, developing solvent isochromatic spectrum condition, just can obtain good thin layer chromatography, contain survey condition and finger printing.That is to say, because each composition interference effect each other in the prescription, cause the finger printing characteristic peak of Radix Ginseng in the compound Chinese medicinal preparation or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or Radix Paeoniae Alba part to change, and have only the condition of the present invention of employing, just can obtain ideal thin layer chromatography, contain survey condition and finger printing.
Proof by experiment, method of quality control of the present invention is more effective to the quality control of the compound Chinese medicinal preparation product made with Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba, and method precision, stability are all higher.
Experimental example 1 is characterized as the preparation of main finger printing with Radix Ginseng Rubra or constituent of ginseng
A, experimental apparatus, reagent and sample:
Reference substance: ginsenoside Rg 1: Nat'l Pharmaceutical ﹠ Biological Products Control Institute
B, chromatographic condition and system suitability experiment:
1. the selection of chromatographic column:
In the research process, having selected conventional octadecylsilane chemically bonded silica for use is the liquid-phase chromatographic column of filler, tried out Zorbax, Inertsil ODS-3 respectively, Diamonsil ODS (is C18,4.6mm * 200mm, 5 μ m) chromatographic column of three kinds of trades mark, result show that the chromatographic column of three kinds of trades mark all can reach separating effect preferably, and wherein Diamonsil ODS chromatographic column separating effect is best, post is imitated the highest, can reach 5400 (calculating with the object of reference ginsenoside Rg1).So finally selecting Diamonsil ODS chromatographic column (4.6mm * 200mm, 5 μ m) for use is the experimentation post.
2. the selection of mobile phase:
Investigated (1) methanol-water (20: 80) in the research process respectively, (2) acetonitrile-water (15: 85), (3) acetonitrile-water (gradient elution) (4) A is a 50mmol.L-1KH2PO4 solution, B is that (the gradient elution volume proportion is from 0 minute to 5 minutes to acetonitrile-water (80: 20), the ratio of Mobile phase B is 25%, from 5 minutes to 40 minutes, the ratio of Mobile phase B rises to 64% by 25%, from 40 minutes to 50 minutes, the ratio of Mobile phase B is 64%, and from 50 minutes to 65 minutes, the ratio of Mobile phase B rose to 80% by 64%, from 65 minutes to 75 minutes, the ratio of Mobile phase B reduced to 25% by 80%) four kinds of flow phase system.The result shows that peak shape is relatively poor under mobile phase (1) condition, and it is less to go out the peak in 1 hour, goes out the peak after still having many components to be trapped in; Under mobile phase (2) the mobile phase condition, peak shape is relatively poor, separates bad; (3) under the condition, the peak hangover is serious, and it is incomplete to go out the peak; Under mobile phase (4) condition, peak shape is better, goes out the peak fully and be evenly distributed, so finally selected.
3. detection wavelength determination:
Be 50mmol.L at A in the research -1KH 2PO 4Solution, B are under acetonitrile-water (80: 20) (gradient elution) the mobile phase condition, have investigated the chromatographic peak situation under different-waveband typical wavelengths 203,210,230,254 respectively, the result shows, chromatographic peak is more under 203nm, and peak shape is better, so finally select for use 203nm as detecting wavelength.
4. instrument, chromatographic column and integral parameter:
4.1 instrument parameter: selected liquid-phase chromatographic analysis field mainstream configuration and well behaved Agilent1100 series of high efficiency chromatograph of liquid for use, the Chemstation chromatographic work station.Chromatographic column is Diamonsil ODS (4.6mm * 200mm, 5 μ m); 40 ℃ of column temperatures, flow velocity 1.0ml/min.
4.2 integral parameter: Slope Sensitivity:1, peak width:0.05, smallest peaks area are 5% of object of reference (S) peak-to-peak area, minimum peak height be the S peak-to-peak high 5%.So setting can be avoided some very calculating of the chromatographic peak of small size (unimodal area accounts for total peak area less than 0.5%), guarantees the dependency with object of reference simultaneously.
5. the preparation of need testing solution:
It is an amount of that precision takes by weighing this product, adds water and make the solution that every 1ml contains 50mg, promptly.
6. the preparation of object of reference solution:
The ginsenoside Rg 1Be one of Radix Ginseng Rubra or Radix Ginseng main active, its integral area proportion in finger printing more greatly and more stable is taken into account the research of intermediate and medical material simultaneously, therefore selected ginsenoside Rg 1As object of reference.
7. finger printing and technical parameter:
Formulate standard finger-print according to 10 batch samples, test sample finger printing and standard finger-print are compared, similarity is all between 0.90~1.00.
Experimental example 2 is based on the preparation of the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics
A, experimental apparatus, reagent and sample:
Reference substance: peoniflorin: Nat'l Pharmaceutical ﹠ Biological Products Control Institute
B, chromatographic condition and system suitability experiment:
1. the selection of chromatographic column:
In the research process, having selected conventional octadecylsilane chemically bonded silica for use is the liquid-phase chromatographic column of filler, has tried out Inertsil ODS-3 (250mm * 4.6mm, 5 μ m) Kromasil C respectively 18(200mm * 4.6mm, 5 μ m), Diamonsil C 18The chromatographic column of (250mm * 4.6mm, 5 μ m) three kinds of trades mark, the result shows that the chromatographic column of three kinds of trades mark all can reach separating effect preferably, wherein Diamonsil C 18The chromatographic column separating effect is best, and post is imitated the highest, can reach 70000 (calculating with the object of reference peoniflorin).So finally select DiamonsilC for use 18(250mm * 4.6mm, 5 μ m) are the experimentation post.
2. the selection of mobile phase:
Investigated (1) methanol-water (20: 80) in the research process respectively, (2) acetonitrile-water (10: 90), (3) acetonitrile-water (gradient elution) (4) mobile phase A is 80% acetonitrile, Mobile phase B is 0.1% phosphoric acid solution, gradient elution, solvent ratios was from 0 minute to 80 minutes, and the ratio of mobile phase A rises to 70% by 15%, and the ratio of Mobile phase B rises to 30% 4 kind of flow phase system by 85%.The result shows that peak shape is relatively poor under mobile phase (1) condition, and it is less to go out the peak in 1 hour, goes out the peak after still having many components to be trapped in; Under mobile phase (2) the mobile phase condition, peak shape is relatively poor, separates bad; (3) under the condition, the peak hangover is serious, and it is incomplete to go out the peak; Under mobile phase (4) condition, peak shape is better, goes out the peak fully and be evenly distributed, so finally selected.
3. detection wavelength determination:
Be 80% acetonitrile in mobile phase A in the research, Mobile phase B is 0.1% phosphoric acid solution, under the gradient elution mobile phase condition, investigated the chromatographic peak situation under different-waveband typical wavelengths 230,254,270,300 respectively, the result shows, 230nm can take into account kurtosis, separating degree and the baseline of each composition chromatographic peak when detecting, so select 230nm to detect wavelength for this product finger printing.
4. instrument, chromatographic column and integral parameter:
4.1 instrument parameter: selected liquid-phase chromatographic analysis field mainstream configuration and well behaved LC-10Avp high performance liquid chromatograph for use, the WML-2010 chromatographic work station.Chromatographic column is Diamonsil C 18(250mm * 4.6mm, 5 μ m); 40 ℃ of column temperatures, flow velocity 1.0ml/min.
4.2 integral parameter: peak width: 10; Slope: 100; Smallest peaks area: 50000.So setting can be avoided some very calculating of the chromatographic peak of small size (unimodal area accounts for total peak area less than 0.5%), guarantees the dependency with object of reference simultaneously.
5. the preparation of need testing solution:
It is an amount of that precision takes by weighing this product, adds water and make the solution that every 1ml contains 1mg, promptly.
6. the preparation of object of reference solution:
It is an amount of to take by weighing the peoniflorin reference substance, adds methanol and makes the solution that every 1ml contains 0.15mg approximately, shakes up, promptly.
7. finger printing and technical parameter:
Formulate standard finger-print according to 10 batch samples, test sample finger printing and standard finger-print are compared, similarity is all between 0.90~1.00.
One or more thin layer chromatography discrimination method in Radix Paeoniae Rubra or white Peony Root, peoniflorin, the gallic acid in experimental example 3 compound Chinese medicinal preparation:
Feature for outstanding Radix Paeoniae Rubra or white Peony Root, selected Radix Paeoniae Rubra or white Peony Root, peoniflorin, gallic acid as its feature speckle, but because have in the medical material that more and peoniflorin, gallic acid structure are close, composition like the polar phase, usual terms is difficult to reach requirements for quality control, so we have screened following lamellae and unfolding condition Radix Paeoniae Rubra or white Peony Root, peoniflorin, gallic acid are launched:
Condition Problem
Chloroform-ethyl acetate-methanol (7-6-5) silica gel g thin-layer plate dichloromethane methanol formic acid (7-6-5) silica gel G F 254Lamellae chloroform ethanol-glacial acetic acid, (7-2-2) silica gel H lamellae chloroform-ethyl acetate-formic acid, (7-1-2) silica gel g thin-layer plate chloroform-ethyl acetate-glacial acetic acid, (7-1-2) silica gel H lamellae chloroform-ethyl acetate methanol-formic acid, (8-3-3-2) silica gel G F 254Lamellae chloroform-ethyl acetate-methanol-formic acid (6-1.5-1.5-0.5) silica gel g thin-layer plate Reference substance is expanded to the forward position reference substance and is expanded to the forward position reference substance and does not separate, feminine gender has the reference substance of interference not separate, feminine gender has the reference substance of interference not separate, it is clear that feminine gender has the reference substance of interference to be expanded to the forward position separation, and the moderate feminine gender of Rf value is noiseless
Through screening, determined with the silica gel g thin-layer plate to be immobile phase, be developing solvent with chloroform-ethyl acetate-methanol-formic acid (6-1.5-1.5-0.5), with this understanding, the Rf value of peoniflorin, gallic acid is moderate, and it is clear to separate with other speckle, and is negative noiseless.
The liquid chromatograph discrimination method of peoniflorin in experimental example 4 compound Chinese medicinal preparation:
Feature for the outstanding Radix Paeoniae Rubra or the Radix Paeoniae Alba, except the thin layer discrimination method, selected peoniflorin as its characteristic component, but owing to there is composition like more, the polar phase close in the medical material with the peoniflorin structure, usual terms is difficult to reach requirements for quality control, so we have screened following chromatographic column and with mobile phase peoniflorin are separated:
Condition Problem
Methyl alcohol-0.05mol/L sodium hydrogen phosphate (80: 20) eight alkyl silane bonded silica gel acetonitriles-0.05mol/1 sodium hydrogen phosphate (40: 60) octadecylsilane chemically bonded silica methyl alcohol-oxolane 0.05mol/L sodium hydrogen phosphate (20: 10: 70) octadecylsilane chemically bonded silica acetonitrile-oxolane-0.05mol/L sodium hydrogen phosphate (20: 10: 70) octadecylsilane chemically bonded silica methyl alcohol-oxolane-1% glacial acetic acid aqueous solution (20: 10: 70) octadecylsilane chemically bonded silica acetonitrile-oxolane-1% glacial acetic acid aqueous solution (20: 10: 70) octadecylsilane chemically bonded silica methyl alcohol-0.1% phosphate aqueous solution (40: 60) octadecylsilane chemically bonded silica The too fast feminine gender of appearance time has the feminine gender of interference to have the slightly asymmetric feminine gender of the peak shape of interference to have the slightly asymmetric retention time of the peak shape of interference moderate; The peak is capable sharp-pointed; Symmetry, negative noiseless
Through screening, determined with the octadecylsilane chemically bonded silica to be immobile phase, methanol-0.1% phosphate aqueous solution (40: 60) is a mobile phase, and with this understanding, the peoniflorin retention time is moderate, and the peak is capable sharp-pointed, and symmetry is negative noiseless.
Experimental example 5 compound Chinese medicinal preparation ginsenoside Rgs 1, ginsenoside Rb 1, ginsenoside Re, ginsenoside Rf the thin layer chromatography discrimination method
For the feature of outstanding Radix Ginseng or Radix Ginseng Rubra, selected the ginsenoside Rg 1, ginsenoside Rb 1, ginsenoside Re, ginsenoside Rf be as its feature speckle, but owing to exist more and the ginsenoside Rg in the medical material 1, ginsenoside Rb 1, composition like close, the polar phase of ginsenoside Re, ginsenoside Rf's structure, usual terms is difficult to reach requirements for quality control, so we have screened following lamellae and unfolding condition to launching Radix Ophiopogonis:
Condition Problem
(15: 40: 22: (10: 40: 15: lower floor's solution silica gel g thin-layer plate n-butanol-Ethyl formate of 5) placing below 10 ℃-methyl alcohol (5-1-5) silica gel g thin-layer plate n-butanol-Ethyl formate-ethanol (2-1.5-0.5) silica gel H lamellae was determined condition to lower floor's solution silica gel g thin-layer plate chloroform-ethyl acetate of 10) placing below 10 ℃-formic acid-water to lower floor's solution silica gel g thin-layer plate n-butanol-Ethyl formate that chloroform-Ethyl formate-water (20: 60: 10) is placed below 10 ℃-methyl alcohol (10-1-5) silica gel H lamellae chloroform-Ethyl formate-formic acid-water: chloroform-ethyl acetate-methanol-water (15: 40: 22: lower floor's solution silica gel g thin-layer plate of 10) placing below 10 ℃ Reference substance is expanded to the forward position reference substance and is expanded to the forward position reference substance and does not separate, feminine gender has the reference substance of interference not separate, feminine gender has the reference substance of interference not separate, feminine gender has the reference substance of interference not separate, feminine gender has interference separation clear, and the moderate feminine gender of Rf value is noiseless
Through screening, determined with the silica gel g thin-layer plate to be immobile phase, with chloroform-ethyl acetate-methanol-water (15: 40: 22: 10) lower floor's solution of placing below 10 ℃ was developing solvent, with this understanding, the ginsenoside Rg 1, ginsenoside Rb 1, ginsenoside Re, ginsenoside Rf Rf value moderate, it is clear to separate with other speckle, negative noiseless.
Ginsenoside Rg in experimental example 6 compound Chinese medicinal preparation 1, ginsenoside Rb 1, the ginsenoside Re the liquid chromatograph discrimination method
For the feature of outstanding Radix Ginseng or Radix Ginseng Rubra, selected the ginsenoside Rg 1, ginsenoside Rb 1, the ginsenoside Re is as its characteristic component, but owing to exist more and the ginsenoside Rg in the medical material 1, ginsenoside Rb 1, Panax Notoginseng saponin R 1Structure is close, composition like the polar phase, and usual terms is difficult to reach requirements for quality control, so we have screened following chromatographic column and mobile phase to the ginsenoside Rg 1, ginsenoside Rb 1, the ginsenoside Re separates:
Condition Problem
Methyl alcohol-0.05mol/L sodium dihydrogen phosphate (70: 30) octadecylsilane chemically bonded silica acetonitrile-0.05mol/L sodium dihydrogen phosphate (55: 45) octadecylsilane chemically bonded silica methyl alcohol-0.05mol/L sodium hydrogen phosphate (80: 20) eight alkyl silane bonded silica gel methyl alcohol-0.05mol/L sodium hydrogen phosphate (80: 20) octadecylsilane chemically bonded silica acetonitrile-0.02mol/L potassium dihydrogen phosphate (90: 10) eight alkyl silane bonded silica gel methyl alcohol-0.02mol/L potassium dihydrogen phosphate (85: 15) octadecylsilane chemically bonded silica The too fast feminine gender of the too fast appearance time of appearance time has the feminine gender of interference to have the feminine gender of interference to have the feminine gender of interference that interference is arranged
Acetonitrile-water is a mobile phase, gradient elution, and solvent ratios is from 0 minute to 35 minutes, the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile
Retention time is moderate, and the peak is capable sharp-pointed, rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29
Symmetry, negative noiseless %, from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% octadecylsilane chemically bonded silica by 29%
Through screening, determined with the octadecylsilane chemically bonded silica to be immobile phase, acetonitrile-water is a mobile phase, gradient elution, solvent ratios are from 0 minute to 35 minutes, and the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29%, from 70 minutes to 100 minutes, the ratio of acetonitrile rises to 40% by 29%, with this understanding, and the ginsenoside Rg 1, ginsenoside Rb 1, ginsenoside Re's retention time is moderate, the peak is capable sharp-pointed, symmetry is negative noiseless.
Experimental example 7 total polysaccharides assays
1 instrument, reagent
Instrument: the general logical TU-1810SPC ultraviolet/visible spectrophotometer of analysing
SARTORIUS BP211D electronic analytical balance
Reagent: phenol analytical pure Tianjin chemical reagent six subsidiary factories of factory
The pure Tianjin of acid analysis chemical reagent three factories
The pure water WAHAHA
2 methods and result
Take by weighing the D-anhydrous glucose 4.44mg that is dried to constant weight at 105 ℃ 2.1 detect the selection precision of wavelength, put in the 100ml measuring bottle, add water and make dissolving and fixed in right amount, shake up to scale, precision is measured 1.2ml, put in the 10ml tool plug test tube, add water to 2ml, the accurate 4% phenol solution 1ml that adds, shake up, add sulphuric acid 7ml rapidly, shake up, insulation is 30 minutes in 40 ℃ of water-baths, take out, cooling is 5 minutes in ice-water bath, shakes up, and scans in 700~400nm wave-length coverage, the result shows, the D-anhydrous glucose has absorption maximum at the 488nm place, and blank noiseless, therefore selecting 488nm is the detection wavelength of astragalus polysaccharides in the spectrophotometry compound Chinese medicinal preparation.
2.2 the preparation of reference substance solution is taken at 105 ℃ of about 5mg of D-anhydrous glucose that are dried to constant weight, the accurate title, decide, and puts in the 100ml measuring bottle, and adding distil water makes dissolving in right amount and decides and shakes up to scale, promptly gets (containing D-anhydrous glucose 0.05mg among every 1ml).
2.3 algoscopy is got this product under the content uniformity item, gets content, mixing, therefrom get about 0.3g, put in the tool plug conical flask, add 80% ethanol 20ml supersound process and make molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and quantitatively is transferred in the 25ml measuring bottle, and adding distil water is fixed to scale, shakes up, precision is measured 1ml, to 10ml tool plug test tube, adding distil water is to 2ml, and precision adds 4% phenol solution 1ml respectively, mixing, add rapidly sulphuric acid 7ml, shake up, 40 ℃ of water-baths 30 minutes, take out, with ice-water bath cooling 5 minutes, taking out immediately, is blank with the retinue solvent, according to spectrophotography (appendix VA of Chinese Pharmacopoeia version in 2000), measure trap at the wavelength place of 488nm.Calculate with one point external standard method, promptly.
The investigation precision of 3 linear relationships takes by weighing the D-anhydrous glucose 4.26mg that is dried to constant weight at 105 ℃, put in the 100ml measuring bottle, add water and make dissolving and fixed to scale in right amount, shake up, precision measures 0.6,0.8,1.2,1.6,2.0ml, split in the 10ml tool plug test tube, add water to 2ml, the accurate respectively 4% phenol solution 1ml that adds shakes up, add sulphuric acid 7ml rapidly, shake up, insulation is 30 minutes in 40 ℃ of water-baths, takes out, cooling is 5 minutes in ice-water bath, shaking up, shake up, is blank with the retinue solvent, according to spectrophotography (appendix VA of Chinese Pharmacopoeia version in 2000), measure trap at the wavelength place of 488nm.With the trap is vertical coordinate, and D-anhydrous glucose concentration (μ g/ml) is abscissa, the drawing standard curve.
D-anhydrous glucose standard curve determination data
Numbering D-anhydrous glucose concentration (μ g/ml) Trap
1 2 3 4 5 2.556 3.408 5.112 6.816 8.520 0.130 0.187 0.262 0.341 0.432
Regression equation Y=0.0492X+0.0104; R=0.998
The D-anhydrous glucose is linear good in 2.556~8.520 μ g/ml scopes.
The test of 4 precision is accurate to take by weighing the D-anhydrous glucose 4.26mg that is dried to constant weight at 105 ℃, puts in the 100ml measuring bottle, adds water and makes dissolving and fixed to scale in right amount, shake up, precision is measured 1.2ml, puts in the 10ml tool plug test tube, add water to 2ml, the accurate 4% phenol solution 1ml that adds shakes up, add sulphuric acid 7ml rapidly, shake up, insulation is 30 minutes in 40 ℃ of water-baths, take out, cooling is 5 minutes in ice-water bath, shakes up, with the retinue solvent is blank, presses operation under the text algoscopy item, METHOD FOR CONTINUOUS DETERMINATION 5 times.
The precision experiment
Numbering 1 2 3 4 5 X is average RSD%
Absorbance 0.262 0.263 0.261 0.262 0.263 0.262 0.32
5 stability tests
5.1 the stability test precision of reference substance solution takes by weighing the D-anhydrous glucose 4.42mg that is dried to constant weight at 105 ℃, put in the 100ml measuring bottle, add water and make dissolving and fixed in right amount to scale, shake up, precision is measured 1.2ml, puts in the 10ml tool plug test tube, add water to 2ml, the accurate 4% phenol solution 1ml that adds shakes up, and adds sulphuric acid 7ml rapidly, shake up, insulation is 30 minutes in 40 ℃ of water-baths, takes out, and cooling is 5 minutes in ice-water bath, shake up, with the retinue solvent is blank, presses operation under the text algoscopy item, measures in the time of 0,10,20,40,60 minute respectively.
The reference substance stability experiment
Time (min) 0 10 20 40 60 X is average RSD%
Absorbance 0.271 0.273 0.275 0.271 0.270 0.272 0.74
5.2 the stability experiment of need testing solution is got powder pin under this product content uniformity item, gets content, porphyrize is therefrom got about 0.3g, and accurate the title decides, and by operating under the text algoscopy item, measures in the time of 0,10,20,40,60 minute respectively.
The test sample stability experiment
Time (min) 0 10 20 40 60 X is average RSD%
Content (mg/ bottle) 2.041 2.112 2.057 2.035 2.084 2.066 1.55
6 replica tests are got powder pin under this product content uniformity item, get content, and porphyrize is therefrom got about 0.3g (totally 6 parts), by operating under the algoscopy item.
The total polysaccharides repeated experiment
Numbering 1 2 3 4 5 X is average RSD%
Content (mg/ bottle) 2.143 2.096 2.125 2.078 2.157 2.120 1.54
7 recovery tests adopt the application of sample absorption method, get this product under the content uniformity item, get content, and mixing is therefrom got about 0.15g (totally 6 parts), splits in the tool plug conical flask; Precision is measured D-anhydrous glucose reference substance solution (0.618mg/ml) 1ml (totally 6 parts), split in the above-mentioned tool plug conical flask, add 80% ethanol 20ml supersound process and make molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and quantitatively is transferred in the 25ml measuring bottle, adding distil water is fixed to scale, shake up, precision is measured 1ml, to 10ml tool plug test tube, adding distil water is to 2ml, precision adds 4% phenol solution 1ml respectively, and mixing adds sulphuric acid 7ml rapidly, shake up, 40 ℃ of water-baths 30 minutes are taken out, immediately with ice-water bath cooling 5 minutes, take out, with the retinue solvent is blank, according to spectrophotography (appendix VA of Chinese Pharmacopoeia version in 2000), measures trap at the wavelength place of 488nm.Calculate with one point external standard method, promptly.The content of total polysaccharides: 4.065mg/g in the compound Chinese medicinal preparation
The average recovery experiment
Numbering Test sample weighing (g) Total polysaccharides amount (mg) in the test sample D-anhydrous glucose addition (mg) Measured value (mg) The response rate (%)
1 2 3 4 5 6 0.15207 0.15526 0.15048 0.15219 0.15004 0.15059 0.6182 0.6311 0.6117 0.6187 0.6099 0.6121 0.618 0.618 0.618 0.618 0.618 0.618 1.2222 1.2376 1.2239 1.2197 1.2173 1.2255 97.74 98.13 99.06 97.25 98.28 99.25
Average recovery rate=98.29% RSD=0.78%
8 three batches of pilot scale sample sizes are measured
Get three batches in this product sample, press the described method of text and handle.
Three batch sample assay results
Lot number Total polysaccharides (mg/ bottle)
1 batch 2 batches 3 batches 2.221 2.314 2.303
Experimental example 8 total saponin contents are measured
1 instrument, reagent
1.1 instrument: the general logical TU-1810SPC ultraviolet/visible spectrophotometer of analysing
SARTORIUS BP211D electronic analytical balance
1.2 reagent: vanillin analytical pure Tianjin recovery fine chemistry industry institute
Methanol chromatographically pure J.T.Baker
Glacial acetic acid analytical pure Shanghai reagent one factory
Chemical plant, prosperous source, perchloric acid analytical pure Tianjin
The pure water WAHAHA
2 methods and result
Take by weighing the ginsenoside Rg 2.1 detect the selection precision of wavelength 15.14mg, put in the 100ml measuring bottle, add an amount of methanol supersound process (power 250W, frequency 33KHz) and make dissolving, add methanol to scale, shake up, precision is measured 1.2ml, puts in the 10ml tool plug test tube water bath method solvent, take out, the accurate 5% vanillin-glacial acetic acid solution 0.2ml that adds, perchloric acid 0.8ml shakes up, put in 60 ℃ of water-baths and heated 15 minutes, take out, in ice-water bath, cooled off 2 minutes immediately, the accurate glacial acetic acid 5ml that adds, shake up, scan in 700~400nm wave-length coverage, the result shows that astragaloside has absorption maximum at the 547nm place, blank noiseless, therefore selecting 547nm is the detection wavelength of total saponins in the spectrophotometry compound Chinese medicinal preparation.
2.2 the preparation ginsenoside Rg of reference substance solution 15mg adds methanol and makes the solution that every 1ml contains 0.05mg, promptly.
2.3 this product under the content uniformity item is got in the preparation of need testing solution, gets content, mixing, therefrom get about 50mg, the accurate title, decide, and puts in the 25ml measuring bottle, add an amount of supersound process of methanol (power 250W, frequency 33KHZ) and make dissolving, take out, put to room temperature, add methanol to scale, shake up, precision is measured 1.0ml, put in the 10ml tool plug test tube, the water bath method solvent takes out, the accurate 5% vanillin-glacial acetic acid solution 0.2ml that adds, perchloric acid 0.8ml, shake up, put in 60 ℃ of water-baths and heated 15 minutes, take out, in ice-water bath, cooled off 2 minutes immediately, the accurate glacial acetic acid 5ml that adds shakes up, and is blank with the retinue solvent, according to spectrophotography (appendix VA of Chinese Pharmacopoeia version in 2000), measure trap at the wavelength place of 547nm.Calculate with one point external standard method, promptly.
The investigation precision of 3 linear relationships takes by weighing the ginsenoside Rg 1Reference substance 5.03mg puts in the 100ml measuring bottle, adds an amount of supersound process of methanol (power 250W, frequency 33KHZ) makes dissolving, take out, put to room temperature, add methanol to scale, shake up, precision measures 0.4,0.8,1.2,1.6,2.0ml, split in the 10ml tool plug test tube, the water bath method solvent takes out, the accurate 5% vanillin-glacial acetic acid solution 0.2ml that adds, perchloric acid 0.8ml, shake up, put in 60 ℃ of water-baths and heated 15 minutes, take out, in ice-water bath, cooled off 2 minutes immediately, the accurate glacial acetic acid 5ml that adds shakes up, and is blank with the retinue solvent, according to spectrophotography (appendix VA of Chinese Pharmacopoeia version in 2000), measure trap at the wavelength place of 547nm.With the trap is vertical coordinate, and the amount of astragaloside (μ g) is an abscissa, the drawing standard curve.
Regression equation Y=0.0062X+0.0047; R=0.9999
The ginsenoside Rg 1Linear good in 20.12~100.6 μ g scopes.
The ginsenoside Rg 1The standard curve determination data
Numbering The ginsenoside Rg 1(μg) Trap
1 2 3 4 5 20.12 40.24 60.36 80.48 100.6 0.127 0.255 0.377 0.502 0.624
3 precision test precision is measured reference substance solution (0.0503mg/ml) 1.2ml, puts in the 10ml tool plug test tube water bath method solvent, take out accurate 5% vanillin-glacial acetic acid solution 0.2ml, the perchloric acid 0.8ml of adding, shake up, put in 60 ℃ of water-baths and heated 15 minutes, take out, in ice-water bath, cooled off 2 minutes immediately, the accurate glacial acetic acid 5ml that adds shakes up, and is blank with the retinue solvent, press operation under the text algoscopy item, METHOD FOR CONTINUOUS DETERMINATION 5 times.
The precision experiment
Numbering 1 2 3 4 5 X is average RSD%
Absorbance 0.376 0.374 0.378 0.377 0.379 0.377 0.51
5 stability tests
5.1 the stability test precision of reference substance solution is measured reference substance solution (0.0503mg/ml) 1.2ml, puts in the 10ml tool plug test tube water bath method solvent, take out accurate 5% vanillin-glacial acetic acid solution 0.2ml, the perchloric acid 0.8ml of adding, shake up, put in 60 ℃ of water-baths and heated 15 minutes, take out, in ice-water bath, cooled off 2 minutes immediately, the accurate glacial acetic acid 5ml that adds shakes up, and is blank with the retinue solvent, press operation under the text algoscopy item, in the time of 0,10,20,40,60 minute, measure respectively.
The reference substance solution stability experiment
Time (min) 0 10 20 40 60 Average RSD%
Absorbance 0.375 0.368 0.381 0.374 0.372 0.374 1.27
5.2 the stability experiment of need testing solution is got this product under this product content uniformity item, gets content, porphyrize is therefrom got about 50mg, by operating under the text algoscopy item, measures in the time of 0,10,20,40,60 minute respectively.
The need testing solution stability experiment
Time (min) 0 10 20 40 60 Average RSD%
Content (mg/ bottle) 13.04 12.81 12.59 12.95 12.88 12.85 1.33
6 replica tests are got this product under this product content uniformity item, get content, and porphyrize is therefrom got about 50mg (totally 5 parts), by operating under the text algoscopy item.
Repeated experiment
Numbering 1 2 3 4 5 X is average RSD%
Content (mg/ bottle) 12.74 12.69 12.81 12.96 12.85 12.81 0.81
7 recovery tests adopt the application of sample absorption method, get this product under the content uniformity item, get content, and porphyrize is therefrom got about 25mg (totally 5 parts), and accurate the title decides, and splits in the 25ml measuring bottle; Precision is measured the ginsenoside Rg 1Reference substance solution (0.628mg/ml) 1ml (totally 5 parts), the accurate title, decide, and splits in the above-mentioned 25ml measuring bottle, adds water and make dissolving and fixed to scale in right amount, shake up, precision is measured 1ml, puts in the 10ml tool plug test tube, by operating under the text algoscopy item, with the retinue solvent is blank, measure trap in accordance with the law, press one point external standard method and calculate, promptly.
The content of total saponins: 25.20mg/g in the compound Chinese medicinal preparation
The average recovery experiment
Numbering Test sample weighing (mg) Total saponins amount (mg) in the test sample The ginsenoside Rg 1Addition (mg) Measured value (mg) The response rate (%)
1 2 3 4 5 25.21 24.08 24.73 26.31 27.15 0.6353 0.6068 0.6232 0.6630 0.6842 0.628 0.628 0.628 0.628 0.628 1.2492 1.2236 1.2452 1.2758 1.3048 97.75 98.21 99.04 97.58 98.83
Average recovery rate=98.28% RSD=0.65%
8 three batches of pilot scale sample sizes are measured
Get three batches in this product sample, press the described method of text and handle.
Three batch sample assay results
Lot number Total saponins (mg/ bottle)
1 2 3 15.21 13.46 14.17
Experimental example 9 ginsenoside Rgs 1, ginsenoside Rb 1, the ginsenoside Re content
1. instrument and reagent
(1) instrument: Agilent1100 high performance liquid chromatograph, chemstationsys work station.The TU-1800SPC ultraviolet spectrophotometer.
(2) reagent: ginsenoside Rg 1, ginsenoside Rb 1, the ginsenoside Re: Nat'l Pharmaceutical ﹠ Biological Products Control Institute;
2. detect the selection of wavelength: precision takes by weighing the ginsenoside Rg 1, ginsenoside Rb 1, the ginsenoside Re, split in the 10ml measuring bottle, add methanol dilution and make the solution that every 1ml contains 0.5mg, scan in the 200-400nm wave-length coverage.The ginsenoside Rg 1, ginsenoside Rb 1, the ginsenoside Re all has absorption maximum at the 203nm place, therefore selects the detection wavelength of 203nm as assay.
3. chromatographic condition: Dikma ODS (4.6mm * 250mm, 5um); Mobile phase: acetonitrile-water is a mobile phase, gradient elution, solvent ratios is from 0 minute to 35 minutes, the ratio of acetonitrile is 19%, and from 35 minutes to 55 minutes, the ratio of acetonitrile rose to 29% by 19%, from 55 minutes to 70 minutes, the ratio of acetonitrile is 29%, and from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% by 29%; The detection wavelength is 203nm; Flow velocity: 1.0ml/min.
4. the preparation of reference substance solution: get the ginsenoside Rg 1, ginsenoside Rb 1An amount of with the ginsenoside Re, accurate claim surely, add methanol and make 1ml and contain the ginsenoside Rg 10.20mg, ginsenoside Rb 10.20mg, the mixed solution of ginsenoside Re 0.1mg.
5. the preparation of need testing solution: get this product under the content uniformity item, get content, mixing is therefrom got about 0.5g, and accurate the title decides, and puts in the 5ml measuring bottle, adds to flow mutual-assistance dissolving and be diluted to scale, shakes up, promptly.
With this understanding, negative sample ginsenoside Rg in the disturbed specimen not 1, ginsenoside Rb 1With ginsenoside Re's mensuration, and separating degree is good.
6. ginsenoside Rg 1, ginsenoside Rb 1Take by weighing the ginsenoside Rg with ginsenoside Re's linear relationship precision 110.24mg, ginsenoside Rb 110.09mg, ginsenoside Re 7.54mg, put altogether in the 10ml measuring bottle, it is fixed to scale to add mobile phase, shakes up, product solution (contains the ginsenoside Rg among every 1ml in contrast 11.024mg, ginsenoside Rb 11.009mg, contain ginsenoside Re 0.754mg), precision is measured 2.5ml, puts in the 10ml measuring bottle, adds mobile phase to scale, shakes up, in contrast the product dilute solution.(contain the ginsenoside Rg among every 1ml 10.256mg, contain ginsenoside Rb 10.25225mg, contain ginsenoside Re 0.1885mg) and accurate reference substance solution 3 μ l, 6 μ l, the 10 μ l of drawing; Reference substance dilute solution 2 μ l, 5 μ l, 10 μ l; Injecting chromatograph of liquid, is vertical coordinate with the peak area, the ginsenoside Rg 1Be figure for abscissa, the drawing standard curve with ginsenoside Re's amount.
The ginsenoside Rg 1Linear relationship
Numbering The ginsenoside Rg 1(μg) Peak area
1 2 3 4 5 6 0.512 1.280 2.560 3.072 6.144 10.24 150.63 475.54 890.23 1058.85 2107.02 3538.96
Regression equation: Y=345.01X+1.20;
The coefficient of determination: γ=0.9996;
The ginsenoside Rg 1Good in 0.512~10.240 μ g scope internal linear relation.
Ginsenoside Rb 1Linear relationship
Numbering Ginsenoside Rb 1(μg) Peak area
1 2 3 4 5 6 0.5045 1.2613 2.5225 3.0270 6.0540 10.090 142.08 353.07 715.48 860.21 1709.14 2855.26
Regression equation: Y=282.95X-0.44;
The coefficient of determination: γ=0.9999;
Ginsenoside Rb 1Good in 0.5045~10.090 μ g scope internal linear relation.
Ginsenoside Re's linear relationship
Numbering Ginsenoside Re (μ g) Peak area
1 2 3 4 5 6 0.3770 0.9425 1.8850 2.2620 4.5240 7.5400 184.37 466.91 928.26 1104.76 2216.15 3698.24
Regression equation: Y=490.12X+1.11;
The coefficient of determination: γ=0.9999;
The ginsenoside Re is good in 0.3770~7.5400 μ g scope internal linear relation.
Ginsenoside Rg under the accurate absorption of the 7 reference substance precision test standard curve item 1, the ginsenoside Rg 1(contain the ginsenoside Rg among every 1ml with ginsenoside Re's reference substance dilute solution 10.256mg, ginseng saponin Rb 10.25225mg, contain ginsenoside Re 0.1885mg) and 10 μ l, inject chromatograph of liquid, the record peak area, continuous sample introduction is measured 5 times, investigates the precision of reference substance solution.
The test of reference substance solution precision
Test number (TN) 1 2 3 4 5 Average RSD(%)
The ginsenoside Rg 1Ginsenoside Rb 1The ginsenoside Re 884.26 726.23 921.63 893.71 722.57 922.44 899.04 724.92 925.36 892.35 725.86 917.03 895.89 722.78 930.58 893.05 724.47 923.41 0.62 0.24 0.54
The result shows, the ginsenoside Rg 1, ginsenoside Rb 1Good with ginsenoside Re's reference substance solution precision.
8. stability test
8.1 ginsenoside Rg under the accurate absorption of the reference substance stability test standard curve item 1, the ginsenoside Rg 1(contain the ginsenoside Rg among every 1ml with ginsenoside Re's reference substance dilute solution 10.256mg, ginseng saponin Rb 10.25225mg, contain ginsenoside Re 0.1885mg) and 10 μ l, inject chromatograph of liquid, the record peak area is measured at 0,6,12,24,48 hour sample introduction.
Reference substance solution stability test result
Testing time (h) 0 6 12 24 48 On average RSD(%)
The ginsenoside Rg 1Ginsenoside Rb 1The ginsenoside Re 884.26 726.23 921.63 893.71 722.57 922.44 899.04 724.92 925.36 892.35 725.86 917.03 895.89 722.78 930.58 893.05 724.47 923.41 0.62 0.24 0.54
The result shows, the ginsenoside Rg 1, ginsenoside Rb 1Have good stability with ginsenoside Re's reference substance solution.
8.2 the need testing solution stability test is got this product under the weight differential item, get content, mixing is therefrom got about 0.5g, and accurate the title decides, put in the 5ml measuring bottle, add and flow mutual-assistance dissolving and decide to shake up the accurate 10 μ l that draw to scale, inject chromatograph of liquid, measure at 0,6,12,24,48 hour sample introduction respectively.
Need testing solution stability test result
Testing time (h) 0 6 12 24 48 Average RSD(%)
The ginsenoside Rg 1(mg/ bottle) ginsenoside Rb 1(mg/ bottle) ginsenoside Re (mg/ bottle) 1.114 1.007 0.5215 1.103 1.037 0.5138 1.085 1.015 0.5204 1.108 1.052 0.5192 1.094 1.023 0.5079 1.101 1.027 0.5166 1.04 1.75 1.10
The result shows that need testing solution has good stability.
9. replica test
Get under this product content uniformity item 5 bottles on powder pin, get content, porphyrize is therefrom got about 0.5g, accurately claims surely, puts in the 5ml measuring bottle, adds the mutual-assistance dissolving and shake up to scale surely of flowing, and the accurate 10 μ l that draw inject chromatograph of liquid, measure, promptly.
Replica test
Test number 1 2 3 4 5 Average RSD(%)
The ginsenoside Rg 1(mg/ bottle) ginsenoside Rb 1(mg/ bottle) ginsenoside Re (mg/ bottle) 1.029 1.011 0.5318 1.002 1.003 0.5221 1.034 0.985 0.5204 1.055 0.992 0.5230 1.043 0.989 0.5196 1.033 0.996 0.5230 1.91 1.08 0.95
10. average recovery test
Adopt the application of sample absorption method, get this product under the weight differential item, get content, mixing is therefrom got about 0.25g (totally 5 parts), and accurate the title decides, and splits in the 5ml measuring bottle; Precision takes by weighing the ginsenoside Rg 113.46mg, ginsenoside Rb 113.78mg ginsenoside Re 6.52mg puts in the 25ml measuring bottle altogether, add an amount of supersound process of mobile phase and make dissolving, take out, put to room temperature, add mobile phase to scale, shake up, precision is measured 1ml (totally 5 parts), split in the above-mentioned 5ml measuring bottle, add mobile phase, shake up to scale, the accurate 10 μ l that draw, inject chromatograph of liquid, measure, promptly.
Ginsenoside Rg in the compound Chinese medicinal preparation 1Content: 2.032mg/g;
Ginsenoside Rb in the compound Chinese medicinal preparation 1Content: 1.960mg/g;
Ginsenoside Re's content: 1.029mg/g in the compound Chinese medicinal preparation;
The ginsenoside Rg 1The average recovery test
Numbering Test sample weighing (mg) Pure product amount (mg) in the test sample Pure product addition (mg) Measured value (mg) The response rate (%)
1 2 3 4 5 0.25512 0.25409 0.25033 0.25126 0.25074 0.5184 0.5163 0.5087 0.5106 0.5095 0.5384 0.5384 0.5384 0.5384 0.5384 1.0473 1.0495 1.0376 1.0359 1.0286 98.24 99.03 98.25 97.57 96.42
The ginsenoside Rg 1Average recovery rate=97.90%; RSD=1.00%
Ginsenoside Rb 1The average recovery test
Numbering Test sample weighing (mg) Pure product amount (mg) in the test sample Pure product addition (mg) Measured value (mg) The response rate (%)
1 2 3 4 5 0.25512 0.25409 0.25033 0.25126 0.25074 0.5000 0.4980 0.4906 0.4925 0.4915 0.5512 0.5512 0.5512 0.5512 0.5512 1.0459 1.0382 1.0322 1.0395 1.0372 99.03 98.01 98.25 99.24 99.01
Ginsenoside Rb 1Average recovery rate=98.71%; RSD=0.55%
The test of ginsenoside Re's average recovery
Numbering Test sample weighing (mg) Pure product amount (mg) in the test sample Pure product addition (mg) Measured value (mg) The response rate (%)
1 2 3 4 5 0.25512 0.25409 0.25033 0.25126 0.25074 0.2625 0.2615 0.2576 0.2585 0.2580 0.2608 0.2608 0.2608 0.2608 0.2608 0.5195 0.5156 0.5145 0.5127 0.5167 98.52 97.43 98.52 97.46 99.18
Ginsenoside Re's average recovery rate=98.22%; RSD=0.77%
11. three batches of pilot scale sample sizes are measured
Get three batches in this product sample, press the described method of text and handle.
Three batch sample assay results
Lot number The ginsenoside Rg 1(mg/ bottle) Ginsenoside Rb 1(mg/ bottle) Ginsenoside Re's (mg/ bottle)
1 2 3 1.085 1.211 1.035 1.141 1.058 1.004 0.5114 0.5276 0.5308
Experimental example 7 paeoniflorin contents are measured
1 instrument, reagent
Instrument: JASCO 1580 type high performance liquid chromatographs
Diamond C18 chromatographic column 250 * 4.6mm 5um Di Ma company
SARTARI US BP211D electronic analytical balance
Reagent: acetonitrile chromatographically pure Fisher company
Methanol analytical pure Beijing Chemical Plant
Sodium dihydrogen phosphate analytical pure Beijing chemical reagents corporation
2 methods and result
2.1 chromatographiccondition
Immobile phase: octadecylsilane chemically bonded silica 250 * 4.6mm 5um
Mobile phase: methanol-1% formic acid solution (40: 60)
Flow velocity: 1ml/min
Column temperature: room temperature
Sample size: 10ul
Detect wavelength: 230nm
2.2 the above-mentioned chromatographic condition of system suitability experimental evidence obtains peoniflorin reference substance, sample chromatogram figure, number of theoretical plate n is all greater than 3000.
2.3 the selection of measuring wavelength is through UV scanning, peoniflorin has absorption maximum at 230nm wavelength place, so selected 230nm is for measuring wavelength.
2.4 the preparation precision of reference substance solution takes by weighing through dry 36 hours peoniflorin reference substance 10mg of phosphorus pentoxide vacuum drying apparatus, puts in the 100ml measuring bottle, adds methanol and makes dissolving in right amount and be diluted to scale, shakes up, and promptly gets (containing peoniflorin 0.1mg among every 1ml).
2.5 this product under the content uniformity item is got in the preparation of need testing solution, gets content, mixing, get about 0.1g, the accurate title, decide, and puts in the 100ml measuring bottle, it is an amount of to add methanol, and supersound process (power 250W, frequency 33KHZ) makes dissolving, take out, put coldly, be diluted to scale with methanol, shake up, filter, filter with microporous filter membrane (0.45um), get subsequent filtrate, promptly.
2.6 negative control test for investigating the mensuration whether other adjuvant disturbs peoniflorin, except that the Radix Paeoniae Rubra or the Radix Paeoniae Alba, takes by weighing other adjuvant in the prescription ratio and makes negative control solution and mensuration with need testing solution with method.The result shows that negative sample is measured noiseless to content of paeoniflorin.
The investigation precision of 3 linear relationships takes by weighing through dry 36 hours peoniflorin reference substance 11.48mg of phosphorus pentoxide vacuum drying apparatus, put in the 10ml measuring bottle, adding methanol makes dissolving in right amount and is settled to scale, shake up, precision measures 0.4,0.8,1.2,1.6,2.0ml, puts respectively in the 10ml measuring bottle, be diluted to scale with methanol, shake up, the therefrom accurate respectively 10ul of absorption injects high performance liquid chromatograph, measures by above-mentioned chromatographic condition.With the peak area is vertical coordinate, and peoniflorin amount (ug) is abscissa mapping, drawing standard curve.
Regression equation is Y=1270296.82X+2219.70
γ=0.9999
Peoniflorin is good in 0.4592~2.2960ug scope internal linear.
The standard curve determination data
Numbering Peoniflorin amount (ug) Peak area
1 2 3 4 5 0.4592 0.9184 1.3776 1.8368 2.2960 565516.5 1171490 1783885 2344300 2895713
4 stability tests are got the content 105.19mg under this product content uniformity item, press the operation down of the preparation of text need testing solution and algoscopy item, and every 1 hour replication 1 time, the result shows that within 4 hours need testing solution is stable.
Time (h) 0 1 2 3 4 On average RSD
Peoniflorin (mg/ bottle) 48.47 50.26 49.83 48.52 49.69 49.55 1.65
The test of 5 precision is accurate to take by weighing through dry 36 hours peoniflorin reference substance 11.56mg of phosphorus pentoxide desiccator, presses the preparation and the operation down of algoscopy item of text reference substance solution, repeats to survey 5 times, and the result is as follows:
Test number 1 2 3 4 5 On average RSD
Peak area 1374344 1376226 1378443 1375983 1376550 1376309 0.11
6 replica tests are got 5 parts of this product, and accurate the title decides, and press the preparation and the operation down of algoscopy item of text need testing solution, and the result is as follows:
Test number 1 2 3 4 5 On average RSD
Peoniflorin (mg/ bottle) 48.74 50.12 49.34 48.86 49.27 49.27 1.10
7 recovery tests adopt the application of sample absorption method, get this product under the content uniformity item, get content, and mixing is therefrom got about 50mg (totally 5 parts), and accurate the title decides, and splits in the 100ml measuring bottle; Precision is measured peoniflorin reference substance solution (1.6696mg/ml) 3ml (totally 5 parts), split in the above-mentioned 100ml measuring bottle, add an amount of supersound process of methanol and make dissolving, take out, put cold, add methanol to scale, shake up, filter with microporous filter membrane (0.45um), the accurate subsequent filtrate 10 μ l that draw inject chromatograph of liquid, measure, promptly.
Paeoniflorin content is 98.147mg/g in the compound Chinese medicinal preparation
Numbering Content weighing (mg) Peoniflorin amount (mg) in the content Peoniflorin addition (mg) Measured value (mg) The response rate (%)
1 2 3 4 5 50.42 55.03 47.96 50.14 52.82 4.949 5.401 4.707 4.921 5.184 5.0088 5.0088 5.0088 5.0088 5.0088 9.865 10.36 9.628 9.883 10.10 98.15 99.03 98.24 99.07 98.15
Average recovery rate=98.43%, RSD=0.49%.
The mensuration of 8 samples is pressed the preparation and the operation down of algoscopy item of text need testing solution, measures three batch samples, and the result is as follows:
Lot number Paeoniflorin content (mg/ bottle)
1 batch 2 batches 3 batches 49.54 52.61 53.05
Experimental example 8 Radix Paeoniae Rubra or Radix Paeoniae Alba total glucosides assay
1 instrument, reagent
Instrument: JASCO 1580 high performance liquid chromatographs
SARTORIUS BP211D electronic analytical balance
Reagent: acetonitrile chromatographically pure Di Ma company
Sodium dihydrogen phosphate analytical pure Beijing Yili Fine Chemicals Co., Ltd.
Methanol analytical pure Wei Si experimental article company limited
Sodium hydroxide analytical pure Tianjin Fengchuan Chemical Reagent Science ﹠ Technology Co., Ltd.
Hydrochloric acid analytical pure Tianjin chemical reagent three factories
2 methods and result
2.1 chromatographiccondition
Immobile phase: octadecylsilane chemically bonded silica 250 * 4.6mm 5 μ m
Mobile phase: acetonitrile-0.02mol/L sodium dihydrogen phosphate (20: 80)
Flow velocity: 1ml/min
Column temperature: room temperature
Sample size: 10 μ l
Detect wavelength: 230nm
2.2 the above-mentioned instrument condition of system suitability experimental evidence obtains benzoic acid reference substance, sample chromatogram figure.Its number of theoretical plate n is all greater than 1500.In the sample benzoic acid peak separate with close peak clear fully, separating degree is all greater than 1.5.
2.3 the about 3mg of benzoic acid reference substance is got in the preparation of reference substance solution, the accurate title, decide, and puts in the 100ml measuring bottle, add an amount of supersound process of methanol (power 250W, frequency 33KHZ) and make dissolving, take out, put to room temperature, shake up to scale with methanol is fixed, precision is measured 1ml, put in the 10ml measuring bottle, add methanol and be diluted to scale, shake up, promptly get (containing benzoic acid 0.003mg among every 1ml).
2.4 the preparation of need testing solution is got under this product content uniformity item, gets content, mixing, therefrom get about 50mg, the accurate title, decide, to the 10ml measuring bottle, add an amount of supersound process of 5% sodium hydroxide solution (power 250W, frequency 33KHZ) and made dissolving in 10 minutes, take out, put to room temperature, fixed with 5% sodium hydroxide solution to scale, shake up, filter, precision is measured subsequent filtrate 1ml, to 10ml tool plug test tube, boiling water bath hydrolysis 2 hours, take out, put, quantitatively be transferred in the 50ml measuring bottle to room temperature, transfer PH=6 with dilute hydrochloric acid, thin up shakes up to scale, filters with microporous filter membrane (0.22 μ m), get subsequent filtrate, promptly.
The test of 3 negative controls, takes by weighing other adjuvant in the prescription ratio and makes negative control solution and mensuration by need testing solution with method except that Radix Paeoniae Rubra or Radix Paeoniae Alba total glucosides for investigating the mensuration whether other adjuvant disturbs Radix Paeoniae Rubra or Radix Paeoniae Alba total glucosides.The result shows that negative sample is noiseless to the assay of Radix Paeoniae Rubra or Radix Paeoniae Alba total glucosides.
The about 10mg of benzoic acid reference substance is got in 4 selections of measuring wavelength, the accurate title, decide, put in the 100ml measuring bottle, add an amount of supersound process of methanol (power 250W, frequency 33KHZ) makes dissolving, take out, put to room temperature, fixed with methanol to scale, shake up, precision is measured 1ml, puts in the 10ml measuring bottle, add methanol and be diluted to scale, shake up, press the text Radix Paeoniae Rubra total glycosides and measure item method suggested down, in 200~400nm wave-length coverage, scan, recording reference substance solution has absorption maximum at 227nm wavelength place, determines that therefore 227nm is for measuring the detection wavelength of Radix Paeoniae Rubra total glycosides.
The investigation precision of 5 linear relationships takes by weighing benzoic acid reference substance 3.76mg, puts in the 100ml measuring bottle, adds an amount of supersound process of methanol (power 250W, frequency 33KHZ) makes dissolving, take out, put to room temperature, be diluted to scale with methanol, shake up, precision measures 0.4,0.8,1.2,1.6,2.0ml, puts respectively in the 10ml measuring bottle, be diluted to scale with methanol, shake up, the accurate respectively 10 μ l of absorption inject chromatograph of liquid, measure by above-mentioned chromatographic condition.With the peak area is vertical coordinate, and benzoic acid amount (μ g) is an abscissa, mapping, drawing standard curve.
Regression equation is Y=4158271.28X-5041.0; R=0.9997
Benzoic acid is good in 0.01504~0.07520g scope internal linear.
The standard curve determination data
Numbering Benzoic acid amount (μ g) Peak area
1 2 3 4 5 0.01504 0.03008 0.04512 0.06016 0.07520 57367 120181 180685 249010 305655
It is an amount of that 6 stability test precisions take by weighing this product, presses the operation down of preparation of text need testing solution and algoscopy item, repeated fixed 1 time every 1 hour, and the result shows that within 4 hours need testing solution is stable.
Time (h) 0 1 2 3 4 X is average RSD%
Content (mg/ bottle) 57.92 58.36 58.12 57.68 58.55 58.13 0.59
7 precision test precision takes by weighing benzoic acid reference substance 3.76mg, presses the preparation and the operation down of algoscopy item of text reference substance solution, repeats to survey 5 times, and the result is as follows:
Test number 1 2 3 4 5 X is average RSD%
Peak area 177046 175307 176874 175465 177235 176385 0.52
8 replica test precisions take by weighing 5 parts of this product, by operating under the preparation of text need testing solution and the algoscopy item.
Test number 1 2 3 4 5 X is average RSD%
Content (mg/ bottle) 59.01 58.37 57.36 59.15 58.21 58.42 1.23
9 recovery tests adopt the application of sample absorption method, get this product under the content uniformity item, get content, and mixing is therefrom got about 25mg (totally 5 parts), and accurate the title decides, and splits in the 10ml measuring bottle; Precision takes by weighing benzoic acid reference substance 10.34mg, puts in the 10ml measuring bottle, adds an amount of supersound process of 5% sodium hydroxide solution and makes dissolving, take out, put, be diluted to scale with 5% sodium hydroxide solution to room temperature, shake up, precision is measured 0.75ml (totally 5 parts), splits in the above-mentioned 10ml measuring bottle, add an amount of supersound process of 5% sodium hydroxide solution (power 250W, frequency 33KHZ) and make dissolving, take out, put to room temperature, be diluted to scale, shake up with 5% sodium hydroxide solution, filter, the accurate subsequent filtrate 1ml that draws puts in the 10ml tool plug test tube, boiling water bath hydrolysis 2 hours, take out, put, quantitatively be transferred in the 50ml measuring bottle to room temperature, transfer PH=6 with dilute hydrochloric acid, thin up shakes up to scale, filters with microporous filter membrane (0.22 μ m), the accurate subsequent filtrate 10 μ l that draw, inject chromatograph of liquid, measure, promptly.
Radix Paeoniae Rubra or Radix Paeoniae Alba total glucosides content are 113.91mg/g in the compound Chinese medicinal preparation, and free benzoic acid content is 5.62mg/g.
Numbering Content weighing (mg) Total glycosides amount (mg) in the content Benzoic acid addition (mg) Record the amount (mg) of total glycosides The response rate (%)
1 2 3 4 5 25.62 28.13 27.69 29.04 28.85 2.918 3.204 3.154 3.308 3.286 0.7755 0.7755 0.7755 0.7755 0.7755 5.922 6.182 6.175 6.218 6.247 98.47 97.62 99.03 95.42 97.06
Average recovery rate=97.52%, RSD=1.43%.
The mensuration of 10 samples
Press the preparation and the operation down of algoscopy item of text need testing solution, measure three batch samples, the result is as follows:
Lot number Radix Paeoniae Rubra or Radix Paeoniae Alba total glucosides content (mg/ bottle)
1 batch 2 batches 3 batches 56.94 58.13 60.07
The specific embodiment
Embodiment 1: adopt liquid chromatography for measuring to be characterized as main finger printing with Radix Ginseng Rubra or constituent of ginseng
(1) preparation of need testing solution: it is an amount of that precision takes by weighing prescription powder injection formulation of the present invention, adds water and make the solution that every 1ml contains 50mg, with the microporous filter membrane filtration of 0.45 μ m, gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: precision takes by weighing the ginsenoside Rg 1In right amount, add methanol and make the solution that every 1ml contains 0.3mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler; Mobile phase A is the 0.05mol/L potassium dihydrogen phosphate, and Mobile phase B is acetonitrile-water 80: 20, gradient elution, solvent ratios is from 0 minute to 5 minutes, the ratio of Mobile phase B is 25%, and from 5 minutes to 40 minutes, the ratio of Mobile phase B rose to 64% by 25%, from 40 minutes to 50 minutes, the ratio of Mobile phase B is 64%, and from 50 minutes to 65 minutes, the ratio of Mobile phase B rose to 80% by 64%, from 65 minutes to 75 minutes, the ratio of Mobile phase B reduced to 25% by 80%; Flow velocity is 1.0ml/min, and the detection wavelength is 203 ± 2nm, and column temperature is 40 ℃;
(4) formulation of standard finger-print: the means of testing that is characterized as main standard finger-print with said method as formulation with Radix Ginseng Rubra or constituent of ginseng; Accurate object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, total peak has 5~20, retention time with definite object of reference chromatographic peak is a benchmark, calculates the relative retention time of other total chromatographic peak, and its relative standard deviation must not surpass ± 10%;
(5) be characterized as the means of testing of main finger printing with the described method in (1)~(3) as Radix Ginseng Rubra or constituent of ginseng in the prescription powder injection formulation of the present invention, the finger printing of preparation testing sample;
(6) with the contrast of prescription powder injection formulation finger printing of the present invention and above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of prescription powder injection formulation of the present invention, should be 0.90~1.00;
II. in the prescription powder injection formulation finger printing of the present invention, non-total peak area must not surpass 5% of total peak area;
III. the relative deviation of the relative retention time of total chromatographic peak of other except that the object of reference chromatographic peak and object of reference chromatographic peak must not surpass ± 10%.
Embodiment 2: adopt the finger printing of liquid chromatography for measuring based on the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics
(1) preparation of need testing solution: it is an amount of that precision takes by weighing prescription powder injection formulation of the present invention, adds water and make the solution that every 1ml contains 1mg, shakes up, promptly;
(2) preparation of object of reference solution: it is an amount of that precision takes by weighing peoniflorin, adds methanol and make the solution that every 1ml contains 0.15mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler; Mobile phase A is 80% acetonitrile, and Mobile phase B is 0.1% phosphoric acid solution, gradient elution, and solvent ratios was from 0 minute to 80 minutes, and the ratio of mobile phase A rises to 70% by 15%, and the ratio of Mobile phase B rises to 30% by 85%; Flow velocity is 1.0ml/min, and the detection wavelength is 230 ± 2nm, and column temperature is 40 ℃;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the standard finger-print of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics; Accurate respectively object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~20;
(5) with the described method in (1)~(3) as in the powder injection formulation based on the means of testing of the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of powder injection formulation, should be 0.90~1.00;
II. in the powder injection formulation finger printing, non-total peak area must not surpass 5% of total peak area;
III. the relative deviation of the relative retention time of total chromatographic peak of other except that the object of reference chromatographic peak and object of reference chromatographic peak must not surpass ± 10%.
Embodiment 3: adopt liquid chromatography test Radix Ginseng Rubra or constituent of ginseng to be characterized as main finger printing
(1) preparation of need testing solution: it is an amount of that precision takes by weighing prescription hydro-acupuncture preparation of the present invention, adds methanol and make the solution that every 1ml contains 30mg, shakes up, and microporous filter membrane filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the ginsenoside Rg 1, ginsenoside Rb 1, a kind of among the ginsenoside Re, ginsenoside Rf, add ethanol and make the solution that every 1ml contains 0.5mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase A is a water; B is 60% methanol solution, gradient elution, solvent ratios are from 0 minute to 10 minutes, and the ratio of Mobile phase B is 20%, from 10 minutes to 30 minutes, the ratio of Mobile phase B rises to 60% by 20%, and from 30 minutes to 50 minutes, the ratio of Mobile phase B was 60%, from 50 minutes to 65 minutes, the ratio of Mobile phase B rises to 80% by 60%, and from 65 minutes to 75 minutes, the ratio of Mobile phase B reduced to 20% by 80%; Flow velocity is that 1.5ml/min, detection wavelength are 200nm, 30 ℃ of column temperatures
(4) formulation of standard finger-print: the means of testing that is characterized as main standard finger-print with said method as formulation with Radix Ginseng Rubra or constituent of ginseng; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, in the described standard finger-print, total peak has 5~30, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, its relative standard deviation must not surpass ± 20%;
(5) be characterized as the means of testing of main finger printing with said method as Radix Ginseng Rubra or constituent of ginseng in the prescription hydro-acupuncture preparation of the present invention, the finger printing of preparation testing sample;
(6) with the finger printing and the contrast of above-mentioned standard finger-print of prescription hydro-acupuncture preparation of the present invention, meet the following requirements:
I. calculate the similarity of the finger printing and the standard finger-print of hydro-acupuncture preparation, should be 0.80~1.00;
II. in the hydro-acupuncture preparation finger printing, non-total peak area must not surpass 10% of total peak area;
III. the relative deviation of the relative retention time of total chromatographic peak of other except that the object of reference chromatographic peak and object of reference chromatographic peak must not surpass ± 20%.
Embodiment 4: adopt the finger printing of liquid chromatography test based on the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics
(1) preparation of need testing solution: it is an amount of that precision is got prescription hydro-acupuncture preparation of the present invention, adds ethanol and make the solution that every 1ml contains 5mg, shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get peoniflorin, add ethanol and make the solution that every 1ml contains 0.05mg,, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase A is 30% methanol, Mobile phase B is a 2.0mol/L sodium dihydrogen phosphate gradient elution, solvent ratios was from 0 minute to 80 minutes, the ratio of mobile phase A rises to 80% by 20%, and the ratio of Mobile phase B rises to 20% by 80%; Flow velocity is 1.6ml/min, detects wavelength 235nm, in 25 ℃ of scopes of column temperature;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulating standard finger-print, is benchmark with the retention time of the object of reference chromatographic peak determined, calculates the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~30;
(5) with said method as in the prescription hydro-acupuncture preparation of the present invention based on the means of testing of the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing and the contrast of above-mentioned standard finger-print of prescription hydro-acupuncture preparation of the present invention, meet the following requirements:
I. calculate the similarity of the finger printing and the standard finger-print of hydro-acupuncture preparation, should be 0.80~1.00;
II. in the hydro-acupuncture preparation finger printing, non-total peak area must not surpass 10% of total peak area;
III. the relative deviation of the relative retention time of total chromatographic peak of other except that the object of reference chromatographic peak and object of reference chromatographic peak must not surpass ± 20%.
Embodiment 5: Radix Ginseng Rubra or Radix Ginseng, ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more thin layer chromatography discrimination method among the ginsenoside Re, ginsenoside Rf
It is an amount of to get prescription powder injection formulation of the present invention, uses n-butanol extraction, filters, and filtrate is as need testing solution; Other gets Radix Ginseng Rubra or Radix Ginseng control medicinal material, ginsenoside Rg 1, ginsenoside Rb 1, among the ginsenoside Re, ginsenoside Rf one or more, preparation control medicinal material solution; The preparation of Radix Ginseng Rubra or Radix Ginseng control medicinal material solution: get Radix Ginseng Rubra or the Radix Ginseng control medicinal material is an amount of, add the chloroform reflux, extract,, discard chloroform liquid, residue adds water-saturated n-butanol and extracts, and extracting solution adds ammonia solution, divides and gets the upper strata, evaporate to dryness, residue dissolve with methanol, medical material solution in contrast; The preparation of reference substance solution: get the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re, ginsenoside Rf, add methanol respectively and make the solution that every 1ml contains 2mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 5 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-water 15: 40: 22: 10 was developing solvent at lower floor's solution of placing below 10 ℃, launch, take out, dry, spray is with 10% sulphuric acid ethanol reagent, and 105 ℃ are dried by the fire to the speckle colour developing clearly, put respectively under daylight and the ultra-violet lamp 365nm and inspect, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the speckle of same color, negative noiseless.
Embodiment 6: ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more liquid chromatograph is differentiated among the ginsenoside Re
It is an amount of to get prescription powder pin of the present invention, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re methanol solution be contrast, adopt liquid chromatography, the chromatographic column octadecylsilane chemically bonded silica is a filler, acetonitrile-water is a mobile phase, gradient elution, solvent ratios are from 0 minute to 35 minutes, and the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29%, from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% by 29%; Flow velocity is 1.0ml/min, detects wavelength 203nm, and column temperature is at 30 ℃; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end, negative noiseless.
Embodiment 7: one or more thin layer chromatography discrimination method in Radix Paeoniae Rubra or white Peony Root, peoniflorin, the gallic acid in the compound Chinese medicinal preparation
It is an amount of to get prescription powder pin of the present invention, adds methanol extraction, centrifugal, gets supernatant as need testing solution; Other gets one or more preparation contrast solutions in Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, peoniflorin, the gallic acid; The preparation of Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution: get Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, add ethanol extraction, filter, filtrate volatilizes, residue dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get peoniflorin, gallic acid reference substance, add methanol respectively and make the solution that every 1ml contains peoniflorin 2mg, gallic acid 0.5mg respectively; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 5 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-formic acid 6: 1.5: 1.5: 0.5 was developing solvent, launches, take out, dry, spray is with 5% ferric chloride alcoholic solution, in the test sample chromatograph earlier, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the same color speckle; Spray again with behind the vanillin sulfuric acid solution 105 ℃ dry by the fire to speckle colour developing clear or, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the same color speckle.
Embodiment 8: the liquid chromatograph discrimination method of peoniflorin in the compound Chinese medicinal preparation:
It is an amount of to get prescription powder pin of the present invention, adds dissolve with methanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and methanol-0.1% formic acid solution was a mobile phase in 40%: 60%, and the detection wavelength is 230nm; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
Embodiment 9: Radix Ginseng Rubra or Radix Ginseng, ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more thin layer chromatography discrimination method among the ginsenoside Re, ginsenoside Rf
It is an amount of to get prescription dispersible tablet of the present invention, uses ethyl acetate extraction, filters, and filtrate is as need testing solution; Other gets Radix Ginseng Rubra or Radix Ginseng control medicinal material, ginsenoside Rg 1, ginsenoside Rb 1, among the ginsenoside Re, ginsenoside Rf one or more, the preparation contrast solution; The preparation of Radix Ginseng Rubra or Radix Ginseng control medicinal material solution: get Radix Ginseng Rubra or the Radix Ginseng control medicinal material is an amount of, add the chloroform reflux, extract,, discard chloroform liquid, residue adds ethyl acetate extraction, and extracting solution adds ammonia solution, divides and gets the upper strata, evaporate to dryness, residue dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re, ginsenoside Rf, add ethanol respectively and make the solution that every 1ml contains 2mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 15 μ l of above-mentioned solution, put in same silica gel G F respectively 254On the lamellae, with n-butyl alcohol-Ethyl formate-upper strata of 5: 18 of water is developing solvent, launches, and takes out, dry, spray is with 50% sulphate reagent, and 150 ℃ are dried by the fire to the speckle colour developing clearly, put respectively under daylight and the ultra-violet lamp 365nm and inspect, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the speckle of same color, negative noiseless.
Implement 10: ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more liquid chromatograph is differentiated among the ginsenoside Re:
It is an amount of to get prescription drop pill of the present invention, puts in the measuring bottle, adds water to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re alcoholic solution be contrast, adopt liquid chromatography, chromatographic column is a filler with eight alkyl silane bonded silica gels, methanol-2.0% glacial acetic acid aqueous solution was a mobile phase in 15%: 85%, gradient elution, solvent ratios is from 0 minute to 30 minutes, the ratio of methanol is 15%, from 30 minutes to 50 minutes, the ratio of methanol rises to 30% by 15%, and from 50 minutes to 70 minutes, the ratio of methanol was 30%, from 70 minutes to 100 minutes, the ratio of methanol rose to 40% by 30%; Flow velocity is 1.5ml/min, detects wavelength 200nm, and column temperature is at 50 ℃; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end, negative noiseless.
Embodiment 11: one or more thin layer chromatography discrimination method in Radix Paeoniae Rubra or white Peony Root, peoniflorin, the gallic acid in the compound Chinese medicinal preparation:
It is an amount of to get prescription liquid drugs injection of the present invention, adds ethyl acetate extraction, filters and gets filtrate as need testing solution; Other gets one or more preparation contrast solutions in Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, peoniflorin reference substance, the gallic acid reference substance; The preparation of Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution: get Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, add ethyl acetate extraction, filter, filtrate volatilizes, residue dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get peoniflorin reference substance, gallic acid reference substance, merge and add ethanol and make the solution that every 1ml contains 3mg; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw above-mentioned need testing solution and Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution, each 18 μ l of peoniflorin gallic acid mixing reference substance solution, put respectively on same silica gel H lamellae, with dichloromethane-Ethyl formate-alcohol-water 15: 50: 10: lower floor's solution of 8 was developing solvent, launch, take out, dry, spray is with 5% ferric chloride alcoholic solution earlier, in the test sample chromatograph, with control medicinal material chromatograph or the corresponding position of reference substance chromatograph on, show the same color speckle; It is clear or put under the ultra-violet lamp 365nm and inspect to speckle colour developing to spray with vanillin sulfuric acid solution after heat wind again, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the same color speckle;
Embodiment 12: the liquid chromatograph discrimination method of peoniflorin in the compound Chinese medicinal preparation
It is an amount of to get prescription micropill of the present invention, adds ethanol or mobile phase or water dissolution or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Alcoholic solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and chromatographic column is a filler with eight alkyl silane bonded silica gels, and 30%: 70% acetonitrile-water is a mobile phase, and the detection wavelength is 235nm; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
Embodiment 13: ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more assay among the ginsenoside Re
It is an amount of to get prescription powder injection formulation of the present invention, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re methanol solution be contrast, adopt liquid chromatography, the chromatographic column octadecylsilane chemically bonded silica is a filler, acetonitrile-water is a mobile phase, gradient elution, solvent ratios are from 0 minute to 35 minutes, and the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29%, from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% by 29%; Flow velocity is 1.0ml/min, detects wavelength 203nm, and column temperature is 30 ℃; Calculate with external standard method or standard curve method, prescription powder injection formulation of the present invention is unit quantity to be equivalent to every day with output, and content limit should be with the next item down or several:
(1) the per unit amount contains the ginsenoside Rg 1Limit must not be less than 1.6mg;
(2) the per unit amount limit that contains the ginsenoside Re must not be less than 0.8mg;
(3) the per unit amount contains ginsenoside Rb 1Limit must not be less than 1.0mg;
(4) the per unit amount contains the ginsenoside Rg 1, the ginsenoside Re the limit of summation must not be less than 3.4mg.
Embodiment 14: the assay of total saponins in the compound Chinese medicinal preparation
It is an amount of to get prescription powder injection formulation of the present invention, puts in the 10ml measuring bottle, adds water to scale, shake up, precision is measured 0.6ml, to the 25ml measuring bottle, water bath method takes out immediately, and precision adds 5% vanillin-glacial acetic acid solution 0.5ml, perchloric acid 2.0ml shakes up, and heating is 15 minutes in 60 ℃ of water-baths, take out, with ice-water bath cooling 2 minutes, precision added glacial acetic acid to 25ml immediately, shake up, as need testing solution; With the ginsenoside Rg 1Be reference substance, get reference substance solution with legal system.With the retinue solvent is blank, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place at 547nm measures trap, calculate with external standard method or standard curve method, prescription powder injection formulation of the present invention is unit quantity to be equivalent to every day with output, and the per unit amount contains total saponins with the ginsenoside Rg 1Meter must not be less than 6mg.
Embodiment 15: the assay of total polysaccharides in the compound Chinese medicinal preparation
It is an amount of to get prescription powder injection formulation of the present invention, adds 80% ethanol 20ml, and supersound process makes molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and is diluted to suitable concn, shakes up, precision is measured in right amount, to 10ml tool plug test tube, adding distil water is to 2ml, and precision adds 4% phenol solution 1ml, mixing, add rapidly sulphuric acid 7ml, shake up, 40 ℃ of water-baths 30 minutes, take out, with ice-water bath cooling 5 minutes, taking out immediately, is blank with the retinue solvent, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place at 488nm measures trap, calculates with one point external standard method or standard curve method, and prescription powder injection formulation of the present invention is unit quantity to be equivalent to every day with output, the per unit amount contains total polysaccharides in anhydrous glucose, must not be less than 3.2mg.
Embodiment 16: content of paeoniflorin is measured in the compound Chinese medicinal preparation
It is an amount of to get prescription powder injection formulation of the present invention, adds dissolve with methanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and methanol-0.1% formic acid solution was a mobile phase in 40%: 60%, and the detection wavelength is 230nm; Calculate with one point external standard method, powder injection formulation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains peoniflorin must not be less than 20mg.
Embodiment 17: the assay of Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides in the compound Chinese medicinal preparation
It is an amount of to get prescription powder injection formulation of the present invention, puts in the measuring bottle, adds 5% sodium hydroxide solution and makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the tool plug test tube, put the boiling water bath hydrolysis 2 hours, and took out, put to room temperature, quantitatively be transferred in the 10ml measuring bottle, swing repeatedly with methanol or mobile phase and to wash test tube wall, fixed to scale, shake up, filter with microporous filter membrane, get subsequent filtrate as need testing solution; Methanol solution with the benzoic acid reference substance is contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, acetonitrile-0.02mol/L sodium dihydrogen phosphate was a mobile phase in 20%: 80%, the detection wavelength is 230nm, 35 ℃ of column temperatures; Calculate behind the content again by formula Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides content %=benzoic acid content % * 480.48/122.13 with one point external standard method, calculate the content of Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides, powder injection formulation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides must not be less than 30mg.
Embodiment 18: ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more assay among the ginsenoside Re
It is an amount of to get prescription dispersible tablet formulation of the present invention, puts in the measuring bottle, adds water to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re alcoholic solution be contrast, adopt liquid chromatography, chromatographic column is a filler with eight alkyl silane bonded silica gels, methanol-2.5% formic acid solution is a mobile phase, gradient elution, solvent ratios are from 0 minute to 25 minutes, and the ratio of methanol is 25%, from 25 minutes to 45 minutes, the ratio of methanol rises to 35% by 25%, and from 45 minutes to 60 minutes, the ratio of methanol was 35%, from 60 minutes to 90 minutes, the ratio of acetonitrile rose to 45% by 35%; Flow velocity is 1.5ml/min, and detecting wavelength is that 204nm or evaporation photodetector detect, in 50 ℃ of scopes of column temperature; Calculate with one point external standard method or standard curve method, dispersible tablet formulation is unit quantity to be equivalent to every day with output, and content limit should be with the next item down or several:
(5) the per unit amount contains the ginsenoside Rg 1Limit must not be less than 0.8mg;
(6) the per unit amount limit that contains the ginsenoside Re must not be less than 0.4mg;
(7) the per unit amount contains ginsenoside Rb 1Limit must not be less than 0.5mg;
(8) the per unit amount contains the ginsenoside Rg 1, the ginsenoside Re the limit of summation must not be less than 1.7mg.
Embodiment 19: it is an amount of that the assay of total saponins is got prescription dropping pill formulation of the present invention in the compound Chinese medicinal preparation, puts in the measuring bottle, and adding distil water makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the measuring bottle, water bath method takes out immediately, and precision adds 25% vanillin-glacial acetic acid solution 2ml, perchloric acid 0.5ml shakes up, and heating is 15 minutes in 80 ℃ of water-baths, take out, with the flowing water cooling, precision adds glacial acetic acid to scale immediately, shake up, as need testing solution, with the ginsenoside Rg 1Or ginsenoside Rb 1Or ginsenoside Re or ginsenoside Rf be reference substance, gets reference substance solution with legal system.With the retinue solvent is blank, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, measure trap, calculate with external standard method or standard curve method at the wavelength place of 547 ± 10nm, dropping pill formulation is unit quantity to be equivalent to every day with output, and the per unit amount contains total saponins with the ginsenoside Rg 1Or ginsenoside Rb 1Or ginsenoside Re or ginsenoside Rf's meter, must not be less than 3mg.
Embodiment 20: total polysaccharides assay in the compound Chinese medicinal preparation
It is an amount of to get prescription liquid drugs injection of the present invention, and it is an amount of to add 85% ethanol, and supersound process makes molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and is diluted to suitable concn, shakes up, precision is measured in right amount, to tool plug test tube, adding distil water is an amount of, and it is an amount of that precision adds 5% phenol solution, mixing, it is an amount of to add rapidly sulphuric acid, shakes up 45 ℃ of water-baths 50 minutes, take out, with ice-water bath cooling 15 minutes, taking out immediately, is blank with the retinue solvent, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place in 488nm ± 10 measures trap, calculates with one point external standard method or standard curve method, and hydro-acupuncture preparation is unit quantity to be equivalent to every day with output, the per unit amount contains total polysaccharides in anhydrous glucose, must not be less than 1.6mg.
Embodiment 21: content of paeoniflorin is measured in the compound Chinese medicinal preparation:
It is an amount of to get prescription pellet preparations of the present invention, is dissolved in water or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Alcoholic solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and chromatographic column is a filler with eight alkyl silane bonded silica gels, and 15%: 85% acetonitrile-water is a mobile phase, and the detection wavelength is 235nm; Calculate with one point external standard method or standard curve method, pellet preparations is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains peoniflorin must not be less than 10mg.
Embodiment 22: the assay of Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides in the compound Chinese medicinal preparation
It is an amount of to get preparation dispersible tablet formulation of the present invention, puts in the measuring bottle, adds 35% sodium hydroxide and makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the tool plug test tube, put the boiling water bath hydrolysis 1 hour, and took out, put to room temperature, quantitatively be transferred in the measuring bottle, swing repeatedly with methanol and to wash test tube wall, fixed to scale, shake up, filter with microporous filter membrane, get subsequent filtrate as need testing solution; Alcoholic solution with the benzoic acid reference substance is contrast, adopts liquid chromatography, and chromatographic column is a filler with eight alkyl silane bonded silica gels, and 35%: 65% methanol-water is a mobile phase, and the detection wavelength is 235nm, 50 ℃ of column temperatures; Calculate behind the content again by formula Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides content %=benzoic acid content % * 480.48/122.13 with one point external standard method or standard curve method, calculate the content of Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides, dispersible tablet formulation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides must not be less than 15mg.
Embodiment 23: adopting liquid chromatography test Radix Codonopsis composition characteristics is main finger printing
(1) preparation of need testing solution: it is an amount of that precision takes by weighing prescription powder injection formulation of the present invention, adds methanol and make the solution that every 1ml contains 50mg, filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active atractylenoide in an amount of codonopsis pilosula, add methanol and make the solution that every 1ml contains 0.1mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is methanol-water 67: 33, and flow velocity is that 1.0ml/min, evaporation photodetector detect, 30 ℃ of drift tube temperatures, and carrier gas flux 2.2L/min, column temperature are 30 ℃;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the standard finger-print of Radix Codonopsis composition characteristics; Accurate respectively object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~20;
(5) with the described method in (1)~(3) as in the prescription powder injection formulation of the present invention based on the means of testing of the finger printing of Radix Codonopsis composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of composing prescription preparation of the present invention and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.90~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 5% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 10%.
Embodiment 24: adopting liquid chromatography test Radix Codonopsis composition characteristics is main finger printing
(1) preparation of need testing solution: it is an amount of to get prescription hydro-acupuncture preparation of the present invention, and thin up shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active reference substance in an amount of codonopsis pilosula, comprise in lobetyolin, the atractylenoide one or both, the water dissolved dilution is to suitable concn, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is 20%: 80% acetonitrile-1.5mol/L sodium dihydrogen phosphate, and flow velocity is 1.8ml/min, and the evaporation photodetector detects 50 ℃ of column temperatures;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the finger printing of Radix Codonopsis composition characteristics; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulating standard finger-print, is benchmark with the retention time of the object of reference chromatographic peak determined, calculates the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~30;
(5) with the described method in (1)~(3) as in the hydro-acupuncture preparation based on the means of testing of the finger printing of Radix Codonopsis composition characteristics, the finger printing of preparation hydro-acupuncture preparation;
(6) with the finger printing of hydro-acupuncture preparation and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of hydro-acupuncture preparation, should be 0.80~1.00;
II. in the hydro-acupuncture preparation finger printing, non-total peak area must not surpass 10% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 20%.
Embodiment 25: the thin layer chromatography discrimination method of lobetyolin in the compound Chinese medicinal preparation
It is an amount of to get prescription powder injection formulation of the present invention, add methanol 25ml, supersound process 30 minutes filters, the filtrate evaporate to dryness, residue adds water 2ml makes dissolving, puts in the C18 solid phase extraction column (500mg is with methanol, each the 10ml prewashing of 20% methanol), use 20% methanol, each 5ml eluting of methanol successively, collect meoh eluate, be concentrated into 1ml, as need testing solution; Other gets the Radix Codonopsis control medicinal material, shines medical material solution in pairs with legal system; It is an amount of to get lobetyolin's reference substance again, adds methanol and makes every 1ml and contain 1mg solution, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw need testing solution 6 μ l, reference substance solution 2 μ l, put respectively on same high-efficient silica gel G lamellae, with n-butyl alcohol-glacial acetic acid-water is developing solvent at 7: 1: 0.5, launches, and takes out, dry, spray is with 10% ethanol solution of sulfuric acid, and 105 ℃ were heated 5 minutes, and put under the ultra-violet lamp 365nm and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color.
Embodiment 26: the liquid chromatograph discrimination method of lobetyolin in the compound Chinese medicinal preparation:
It is an amount of to get prescription powder injection formulation of the present invention, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and acetonitrile-water is a mobile phase at 22: 78, and the detection wavelength is 267nm, 30 ℃ of column temperatures; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
Embodiment 27: the thin layer chromatography discrimination method of lobetyolin in the compound Chinese medicinal preparation
It is an amount of to get prescription powder injection formulation of the present invention, is dissolved in water, and uses n-butanol extraction, and extract is concentrated into dried, the residue dissolve with ethanol, and as need testing solution, other gets one or both preparation contrast solutions in Radix Codonopsis control medicinal material, the lobetyolin; The preparation of control medicinal material solution: get the Radix Codonopsis control medicinal material, filter behind the extracting in water, the filtrate evaporate to dryness, residue is used n-butanol extraction after with water dissolution, and extract is concentrated into dried, the residue dissolve with ethanol, as need testing solution, the preparation of reference substance solution: get lobetyolin's reference substance, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 28 μ l of above-mentioned solution, put respectively on same silica gel H lamellae, n-butyl alcohol-alcohol-water is developing solvent at 25: 7: 1, launches, and takes out, dry, spray is with 28% ethanol solution of sulfuric acid, and 130 ℃ were heated 10 minutes, and put under the ultra-violet lamp 365nm and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color.
Embodiment 28: the liquid chromatograph discrimination method of lobetyolin in the compound Chinese medicinal preparation
It is an amount of to get prescription dispersible tablet of the present invention, puts in the measuring bottle, adds dissolve with ethanol and is diluted to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and chromatographic column is a filler with eight alkyl silane bonded silica gels, and acetonitrile-0.05% phosphate aqueous solution is a mobile phase at 30%: 70%, detects wavelength 265nm, 45 ℃ of column temperatures; In the test sample chromatograph, answer tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
Embodiment 29: the assay of lobetyolin in the compound Chinese medicinal preparation
It is an amount of to get prescription dispersible tablet formulation of the present invention, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and chromatographic column is a filler with eight alkyl silane bonded silica gels, and methanol-1.5% glacial acetic acid aqueous solution is a mobile phase at 60%: 40%, detects wavelength 265nm, 40 ℃ of column temperatures; Calculate with one point external standard method or standard curve method, dispersible tablet formulation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains lobetyolin must not be less than 0.05mg.
Embodiment 30: the assay of lobetyolin in the compound Chinese medicinal preparation
It is an amount of to get prescription powder injection formulation of the present invention, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and acetonitrile-water is a mobile phase at 22: 78, and the detection wavelength is 267nm, 30 ℃ of column temperatures; Calculate with one point external standard method or standard curve method, powder injection formulation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains lobetyolin must not be less than 0.1mg.

Claims (8)

1, a kind of method of quality control of the compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba, it is characterized in that: this method comprises following all or part of content:
(1) finger printing of compound Chinese medicinal preparation test, comprise with Radix Ginseng Rubra or constituent of ginseng be characterized as main finger printing, based on the finger printing of Radix Codonopsis composition characteristics with based in the finger printing of Radix Paeoniae Rubra or Radix Paeoniae Alba composition characteristics one or more;
(2) Radix Ginseng Rubra or ginseng crude drug, Radix Paeoniae Rubra or white Peony Root, ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, the differential test method of all or part of composition among the ginsenoside Re, ginsenoside Rf, peoniflorin, gallic acid, lobetyolin, atractylenoide;
(3) ginsenoside Rg in the compound Chinese medicinal preparation 1, ginsenoside Rb 1, ginsenoside Re, peoniflorin, Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides, total polysaccharides, total saponins, lobetyolin, all or part of composition of atractylenoide content test method.
2, according to the method for quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba of claim 1, it is characterized in that: with Radix Ginseng Rubra or constituent of ginseng be characterized as main finger printing, based on the finger printing of Radix Codonopsis composition characteristics with based in the finger printing of Radix Paeoniae Rubra or Radix Paeoniae Alba composition characteristics one or more:
A, employing liquid chromatography test Radix Ginseng Rubra or constituent of ginseng are characterized as main finger printing:
(1) preparation of need testing solution: it is an amount of to get compound Chinese medicinal preparation to be measured, adds water or methanol or dissolve with ethanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active reference substance in an amount of Radix Ginseng Rubra or Radix Ginseng and the Radix Ophiopogonis medical material, comprise the ginsenoside Rg 1, ginsenoside Rb 1, a kind of among the ginsenoside Re, ginsenoside Rf, water or methanol or dissolve with ethanol are settled to suitable concn, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase A is 0.01mol/L~2mol/L sodium dihydrogen phosphate or 0.01mol/L~2mol/L potassium dihydrogen phosphate or water or 0.1%~5% glacial acetic acid solution or 0.1%~5% formic acid solution or 0.02%~5% phosphoric acid solution; B is 10%~90% acetonitrile solution or 10%~90% methanol solution, and gradient elution, flow velocity be 0.5~2.0ml/min, detect wavelength is that one or several or evaporation photodetector in 190~410nm scope detects, and column temperature is in 20~60 ℃ of scopes;
(4) formulation of standard finger-print: the means of testing that is characterized as main standard finger-print with said method as formulation with Radix Ginseng Rubra or constituent of ginseng; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, in the described standard finger-print, total peak has 5~30, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, its relative standard deviation must not surpass ± 20%;
(5) be characterized as the means of testing of main finger printing with the described method in (1)~(3) as Radix Ginseng Rubra or constituent of ginseng in the compound Chinese medicinal preparation to be measured, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.80~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 10% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 20%;
B, employing liquid chromatography are tested the finger printing based on the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics:
(1) preparation of need testing solution: it is an amount of to get compound Chinese medicinal preparation to be measured, adds water or methanol or dissolve with ethanol or dilution, shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get peoniflorin,, be settled to suitable concn, as object of reference solution with methanol or dissolve with ethanol;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is 0.5%~100% acetonitrile solution or methanol: 0.005mol/L~5mol/L sodium dihydrogen phosphate or 0.005mol/L~5mol/L potassium dihydrogen phosphate or 0.1%~5% glacial acetic acid or 0.1%~5% formic acid or 0.005%~5% phosphoric acid solution, gradient elution, flow velocity is that 0.5~2.0ml/min, detection wavelength are one or several in the 190-400nm scope, and column temperature is in 20~60 ℃ of scopes;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulating standard finger-print, is benchmark with the retention time of the object of reference chromatographic peak determined, calculates the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~30;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.80~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 10% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 20%;
C, employing liquid chromatography test Radix Codonopsis composition characteristics are main finger printing:
(1) preparation of need testing solution: it is an amount of to get compound Chinese medicinal preparation to be measured, adds water or methanol or dissolve with ethanol or dilution, shakes up, and filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active reference substance in an amount of codonopsis pilosula, comprise in lobetyolin, the atractylenoide one or both, water or methanol, dissolve with ethanol are diluted to suitable concn, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is 5%~95%: 95%~5% acetonitrile or methanol-water or 0.01mol/L~2mol/L sodium dihydrogen phosphate or 0.2%~3% glacial acetic acid or 0.2%~3% formic acid or 0.2%~3% phosphoric acid solution, flow velocity is 0.5~2.0ml/min, detect wavelength is that one or several or evaporation photodetector in the 190-300nm scope detects, and column temperature is in 20~60 ℃ of scopes;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the finger printing of Radix Codonopsis composition characteristics; According to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulating standard finger-print, is benchmark with the retention time of the object of reference chromatographic peak determined, calculates the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~30;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of Radix Codonopsis composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.80~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 10% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 20%.
3, according to the method for quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba of claim 2, it is characterized in that: this method adopts liquid chromatography test to be characterized as main finger printing with Radix Ginseng Rubra or constituent of ginseng and based on the finger printing of Radix Paeoniae Rubra or Radix Paeoniae Alba composition characteristics:
A, employing liquid chromatography for measuring are characterized as main finger printing with Radix Ginseng Rubra or constituent of ginseng:
(1) preparation of need testing solution: it is an amount of that precision takes by weighing compound Chinese medicinal preparation to be measured, adds water and make the solution that every 1ml contains 50mg, with the microporous filter membrane filtration of 0.45 μ m, gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: precision takes by weighing the ginsenoside Rg 1In right amount, add methanol and make the solution that every 1ml contains 0.3mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler; Mobile phase A is the 0.05mol/L potassium dihydrogen phosphate, and Mobile phase B is acetonitrile-water 80: 20, gradient elution, solvent ratios is from 0 minute to 5 minutes, the ratio of Mobile phase B is 25%, and from 5 minutes to 40 minutes, the ratio of Mobile phase B rose to 64% by 25%, from 40 minutes to 50 minutes, the ratio of Mobile phase B is 64%, and from 50 minutes to 65 minutes, the ratio of Mobile phase B rose to 80% by 64%, from 65 minutes to 75 minutes, the ratio of Mobile phase B reduced to 25% by 80%; Flow velocity is 1.0ml/min, and the detection wavelength is 203 ± 2nm, and column temperature is 40 ℃;
(4) formulation of standard finger-print: the means of testing that is characterized as main standard finger-print with said method as formulation with Radix Ginseng Rubra or constituent of ginseng; Accurate object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, total peak has 5~20, retention time with definite object of reference chromatographic peak is a benchmark, calculates the relative retention time of other total chromatographic peak, and its relative standard deviation must not surpass ± 10%;
(5) be characterized as the means of testing of main finger printing with the described method in (1)~(3) as Radix Ginseng Rubra or constituent of ginseng in the compound Chinese medicinal preparation to be measured, the finger printing of preparation testing sample;
(6) with the contrast of compound Chinese medicinal preparation finger printing to be measured and above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.90~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 5% of total peak area;
III. the relative retention time of total chromatographic peak of other except that the object of reference chromatographic peak and object of reference chromatographic peak and standard finger-print compare, and relative deviation must not surpass ± 10%;
B, adopt the finger printing of liquid chromatography for measuring based on the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics:
(1) preparation of need testing solution: it is an amount of that precision takes by weighing compound Chinese medicinal preparation to be measured, adds water and make the solution that every 1ml contains 1mg, shakes up, promptly;
(2) preparation of object of reference solution: it is an amount of that precision takes by weighing peoniflorin, adds methanol and make the solution that every 1ml contains 0.15mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler; Mobile phase A is 80% acetonitrile, and Mobile phase B is 0.1% phosphoric acid solution, gradient elution, and solvent ratios was from 0 minute to 80 minutes, and the ratio of mobile phase A rises to 70% by 15%, and the ratio of Mobile phase B rises to 30% by 85%; Flow velocity is 1.0ml/min, and the detection wavelength is 230 ± 2nm, and column temperature is 40 ℃;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the standard finger-print of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics; Accurate respectively object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~20;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of the Radix Paeoniae Alba or Radix Paeoniae Rubra composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.90~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 5% of total peak area;
III. the relative retention time of total chromatographic peak of other except that the object of reference chromatographic peak and object of reference chromatographic peak and standard finger-print compare, and relative deviation must not surpass ± 10%;
C, employing liquid chromatography test Radix Codonopsis composition characteristics are main finger printing:
(1) preparation of need testing solution: it is an amount of that precision takes by weighing compound Chinese medicinal preparation to be measured, adds methanol and make the solution that every 1ml contains 50mg, filters, and gets subsequent filtrate as need testing solution;
(2) preparation of object of reference solution: get the main active atractylenoide in an amount of codonopsis pilosula, add methanol and make the solution that every 1ml contains 0.1mg, as object of reference solution;
(3) chromatographic condition: the chromatographic column adopting octadecylsilane chemically bonded silica is a filler: mobile phase is methanol-water 67: 33, and flow velocity is that 1.0ml/min, evaporation photodetector detect, 30 ℃ of drift tube temperatures, and carrier gas flux 2.2L/min, column temperature are 30 ℃;
(4) formulation of standard finger-print: with said method as the means of testing of formulating based on the standard finger-print of Radix Codonopsis composition characteristics; Accurate respectively object of reference solution and each 10 μ l of need testing solution of drawing, inject chromatograph of liquid respectively, according to 10 batches or 10 batches of collection of illustrative plates that above test sample is measured, formulate standard finger-print, retention time with definite object of reference chromatographic peak is a benchmark, calculate the relative retention time of other total chromatographic peak, in the described standard finger-print, total peak has 3~20;
(5) with the described method in (1)~(3) as in the compound Chinese medicinal preparation to be measured based on the means of testing of the finger printing of Radix Codonopsis composition characteristics, the finger printing of preparation testing sample;
(6) with the finger printing of compound Chinese medicinal preparation to be measured and the contrast of above-mentioned standard finger-print, in should meeting the following requirements partly or entirely:
I. calculate the similarity of the finger printing and the standard finger-print of compound Chinese medicinal preparation to be measured, should be 0.90~1.00;
II. in the compound Chinese medicinal preparation finger printing to be measured, non-total peak area must not surpass 5% of total peak area;
III. the total chromatographic peak of other except that the object of reference chromatographic peak is compared with standard finger-print with the relative retention time of object of reference chromatographic peak, and relative deviation must not surpass ± 10%.
4, according to the method for quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba of claim 1, it is characterized in that: the discrimination method of described compound Chinese medicinal preparation comprises following all or part of content:
Radix Ginseng Rubra or Radix Ginseng, ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more thin layer chromatography discrimination method among the ginsenoside Re, ginsenoside Rf:
It is an amount of to get compound Chinese medicinal preparation to be measured, with n-butyl alcohol or ethanol or methanol or ethyl acetate or chloroform extraction, filters, and filtrate is as need testing solution; Other gets Radix Ginseng Rubra or Radix Ginseng control medicinal material, ginsenoside Rg 1, ginsenoside Rb 1, among the ginsenoside Re, ginsenoside Rf one or more, the preparation contrast solution; The preparation of Radix Ginseng Rubra or Radix Ginseng control medicinal material solution: get Radix Ginseng Rubra or the Radix Ginseng control medicinal material is an amount of, add the chloroform reflux, extract,, discard chloroform liquid, residue adds water-saturated n-butanol or ethyl acetate extraction, extracting solution adds ammonia solution, divides and gets upper strata, evaporate to dryness, residue is with methanol or dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re, ginsenoside Rf, add methanol or ethanol respectively and make the solution that every 1ml contains 2mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 1~30 μ l of above-mentioned solution, put respectively in same silica gel g thin-layer plate or silica gel H lamellae or silica gel G F 254On the lamellae, lower floor's solution or n-butyl alcohol-ethyl acetate or the Ethyl formate-water 1~10: 0.2~2 placed below 5~40: 10~100: 5~50: 0.2~3010 ℃ with chloroform-ethyl acetate or Ethyl formate-methanol-water: 1~15 upper strata is developing solvent, launch, take out, dry, spray is with 5~50% sulphuric acid ethanol reagent or 50% sulphate reagent, 80 ℃~160 ℃ dry by the fire to speckle colour developing clear, put respectively under daylight and the ultra-violet lamp 365nm and inspect, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, should show the speckle of same color, negative noiseless;
Ginsenoside Rg in b, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more liquid chromatograph is differentiated among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds water or methanol or mobile phase or ethanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1The methanol of one or more reference substances among the ginsenoside Re or alcoholic solution are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, methanol or acetonitrile-water or 0.5%~5% glacial acetic acid aqueous solution or 0.02%~5% phosphate aqueous solution or 0.5%~5% formic acid solution are mobile phase, gradient elution, flow velocity is 0.5~2.0ml/min, one or several or the evaporation photodetector that detect wavelength and be in 190~410nm scope detect, and column temperature is in 20~60 ℃ of scopes; In the test sample chromatograph, answer tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end, negative noiseless.
One or more thin layer chromatography discrimination method in Radix Paeoniae Rubra or white Peony Root, peoniflorin, the gallic acid in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds ethyl acetate or ethanol or methanol or n-butanol extraction, and filtration or centrifugal is got filtrate or supernatant as need testing solution; Other gets one or more preparation contrast solutions in Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, peoniflorin reference substance, the gallic acid reference substance; The preparation of Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution: get Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, add ethyl acetate or ethanol or methanol or n-butanol extraction, filter, filtrate volatilizes, and residue is with methanol or dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get one or both of peoniflorin reference substance, gallic acid reference substance, respectively or merge and add methanol or ethanol is made the solution that every 1ml contains 0.2~5mg; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw one or more each 1~30 μ l of above-mentioned need testing solution and Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution, peoniflorin reference substance solution, gallic acid reference substance solution, peoniflorin gallic acid mixing reference substance solution, put respectively in same silica gel g thin-layer plate or silica gel H lamellae or silica gel G F 254Lamellae, with lower floor's solution of chloroform or dichloromethane-ethyl acetate or Ethyl formate-methanol or ethanol-formic acid or acetic acid 1~120: 0.2~15: 0.5~25: 0.01~5 or chloroform or dichloromethane-ethyl acetate or Ethyl formate-methanol or alcohol-water 3~50: 10~120: 5~60: 1~25 or chloroform or n-butyl alcohol or dichloromethane or toluene-methanol or glacial acetic acid or formic acid-ethyl acetate or water 1~80: 0.1~50: 0.05~25 or chloroform-methanol 1~25: 0.2~15 is developing solvent, launch, take out, dry, spray is with 0.2%~10% ferric chloride alcoholic solution earlier, in the test sample chromatograph, with control medicinal material chromatograph or the corresponding position of reference substance chromatograph on, should show the same color speckle; Spray again with behind the vanillin sulfuric acid solution 80 ℃~160 ℃ dry by the fire to speckle colour developing clear or hot blast blow clear or put under ultra-violet lamp 365nm or the 254nm and inspect to the speckle colour developing, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, should show the same color speckle;
The liquid chromatograph discrimination method of peoniflorin in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds methanol or ethanol or mobile phase or water dissolution or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol or alcoholic solution with the peoniflorin reference substance are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, methanol or acetonitrile-water or 0.05%~10% glacial acetic acid aqueous solution or 0.05%~10% aqueous formic acid or 0.01%~5% phosphate aqueous solution or 0.005mol/L~2mol/L sodium dihydrogen phosphate or 0.005mol/L~2mol/L potassium dihydrogen phosphate 5%~95%: 95%~5% is a mobile phase, and the detection wavelength is 200~410nm; In the test sample chromatograph, answer tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
The thin layer chromatography discrimination method of lobetyolin in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, be dissolved in water, with n-butyl alcohol or ethyl acetate or chloroform extraction, extract is concentrated into dried, and residue is with methanol or dissolve with ethanol, as need testing solution, or put in C18 or the C8 solid phase extraction column, use 5%~50% methanol, methanol-eluted fractions successively, collect meoh eluate, be concentrated into 1ml, as need testing solution; Other gets one or both preparation contrast solutions in Radix Codonopsis control medicinal material, the lobetyolin; The preparation of control medicinal material solution: get the Radix Codonopsis control medicinal material, filter after adding water or methanol extraction, filtrate evaporate to dryness, residue with water dissolution after with n-butyl alcohol or ethyl acetate or chloroform extraction, extract is concentrated into dried, residue is with methanol or dissolve with ethanol, and as need testing solution, or filtrate is put in C18 or the C8 solid phase extraction column, use 5%~50% methanol, methanol-eluted fractions successively, collect meoh eluate, be concentrated into 1ml, as need testing solution; The preparation of reference substance solution: get lobetyolin's reference substance, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 1~30 μ l of above-mentioned solution, put respectively in same silica gel g thin-layer plate or silica gel H lamellae or silica GF254 lamellae, n-butyl alcohol-glacial acetic acid or formic acid or ethanol or dehydrated alcohol-water 1~35: 0.1~10: 0.05~5 are developing solvent, launch, and take out, dry, spray is with 3%~30% ethanol solution of sulfuric acid, and 80~150 ℃ were heated 1~30 minute, and put under the ultra-violet lamp 365nm and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, should show the fluorescence speckle of same color;
The liquid chromatograph discrimination method of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get medicine group to be measured and thing, puts in the measuring bottle, adds methanol or ethanol or mobile phase to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, methanol or acetonitrile-water or 0.05%~5% glacial acetic acid aqueous solution or 0.02%~0.5% phosphate aqueous solution 5%~80%: 95%~20% are mobile phase, the detection wavelength is one or several in 200~410nm scope, in 20~50 ℃ of scopes of column temperature; In the test sample chromatograph, answer tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
5, according to the method for quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba of claim 4, it is characterized in that: the discrimination method of described compound Chinese medicinal preparation comprises following all or part of content:
Radix Ginseng Rubra or Radix Ginseng, ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more thin layer chromatography discrimination method among the ginsenoside Re, ginsenoside Rf:
It is an amount of to get compound Chinese medicinal preparation to be measured, uses n-butanol extraction, filters, and filtrate is as need testing solution; Other gets Radix Ginseng Rubra or Radix Ginseng control medicinal material, ginsenoside Rg 1, ginsenoside Rb 1, among the ginsenoside Re, ginsenoside Rf one or more, preparation control medicinal material solution; The preparation of Radix Ginseng Rubra or Radix Ginseng control medicinal material solution: get Radix Ginseng Rubra or the Radix Ginseng control medicinal material is an amount of, add the chloroform reflux, extract,, discard chloroform liquid, residue adds water-saturated n-butanol and extracts, and extracting solution adds ammonia solution, divides and gets the upper strata, evaporate to dryness, residue dissolve with methanol, medical material solution in contrast; The preparation of reference substance solution: get the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re, ginsenoside Rf, add methanol respectively and make the solution that every 1ml contains 2mg, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 5 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-water 15: 40: 22: 10 was developing solvent at lower floor's solution of placing below 10 ℃, launch, take out, dry, spray is with 10% sulphuric acid ethanol reagent, and 105 ℃ are dried by the fire to the speckle colour developing clearly, put respectively under daylight and the ultra-violet lamp 365nm and inspect, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the speckle of same color, negative noiseless;
Ginsenoside Rg in b, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more liquid chromatograph is differentiated among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re methanol solution be contrast, adopt liquid chromatography, the chromatographic column octadecylsilane chemically bonded silica is a filler, acetonitrile-water is a mobile phase, gradient elution, solvent ratios are from 0 minute to 35 minutes, and the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29%, from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% by 29%; Flow velocity is 1.0ml/min, detects wavelength 203nm, and column temperature is at 30 ℃; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end, negative noiseless.
One or more thin layer chromatography discrimination method in Radix Paeoniae Rubra or white Peony Root, peoniflorin, the gallic acid in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds methanol extraction, centrifugal, gets supernatant as need testing solution; Other gets one or more preparation contrast solutions in Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, peoniflorin, the gallic acid; The preparation of Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material solution: get Radix Paeoniae Rubra or Radix Paeoniae Alba control medicinal material, add ethanol extraction, filter, filtrate volatilizes, residue dissolve with ethanol, medical material solution in contrast; The preparation of reference substance solution: get peoniflorin, gallic acid reference substance, add methanol respectively and make the solution that every 1ml contains peoniflorin 2mg, gallic acid 0.5mg respectively; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw each 5 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-formic acid 6: 1.5: 1.5: 0.5 was developing solvent, launches, take out, dry, spray is with 5% ferric chloride alcoholic solution, in the test sample chromatograph earlier, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the same color speckle; Spray again with behind the vanillin sulfuric acid solution 105 ℃ dry by the fire to speckle colour developing clear or, in the test sample chromatograph, with control medicinal material chromatograph and the corresponding position of reference substance chromatograph on, show the same color speckle;
The liquid chromatograph discrimination method of peoniflorin in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds dissolve with methanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and methanol-0.1% formic acid solution was a mobile phase in 40%: 60%, and the detection wavelength is 230nm; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end;
The thin layer chromatography discrimination method of lobetyolin in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, add methanol 25ml, supersound process 30 minutes filters, the filtrate evaporate to dryness, residue adds water 2ml makes dissolving, puts in the C18 solid phase extraction column (500mg is with methanol, each the 10ml prewashing of 20% methanol), use 20% methanol, each 5ml eluting of methanol successively, collect meoh eluate, be concentrated into 1ml, as need testing solution; Other gets the Radix Codonopsis control medicinal material, shines medical material solution in pairs with legal system; It is an amount of to get lobetyolin's reference substance again, adds methanol and makes every 1ml and contain 1mg solution, in contrast product solution; Adopt the disclosed thin layer chromatography test of Chinese Pharmacopoeia appendix, draw need testing solution 6 μ l, reference substance solution 2 μ l, put respectively on same high-efficient silica gel G lamellae, with n-butyl alcohol-glacial acetic acid-water is developing solvent at 7: 1: 0.5, launches, and takes out, dry, spray is with 10% ethanol solution of sulfuric acid, and 105 ℃ were heated 5 minutes, and put under the ultra-violet lamp 365nm and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color;
The liquid chromatograph discrimination method of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and acetonitrile-water is a mobile phase at 22: 78, and the detection wavelength is 267nm, 30 ℃ of column temperatures; In the test sample chromatograph, tool and the reference substance chromatograph consistent chromatographic peak of time of withing a hook at the end.
6, according to the method for quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba of claim 1, it is characterized in that: the method for testing of described compound Chinese medicinal preparation content should comprise following all or part of content:
Ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more assay among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds water or methanol or mobile phase or ethanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1The methanol of one or more reference substances among the ginsenoside Re or alcoholic solution are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, methanol or acetonitrile-water or 0.5%~5% glacial acetic acid aqueous solution or 0.02%~5% phosphate aqueous solution or 0.5%~5% formic acid solution are mobile phase, gradient elution, flow velocity is 0.5~2.0ml/min, one or several or the evaporation photodetector that detect wavelength and be in 190~410nm scope detect, and column temperature is in 20~60 ℃ of scopes; Calculate with one point external standard method or standard curve method, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and content limit should be with the next item down or several:
(1) the per unit amount contains the ginsenoside Rg 1Limit must not be less than 0.8mg;
(2) the per unit amount limit that contains the ginsenoside Re must not be less than 0.4mg;
(3) the per unit amount contains ginsenoside Rb 1Limit must not be less than 0.5mg;
(4) the per unit amount contains the ginsenoside Rg 1, the ginsenoside Re the limit of summation must not be less than 1.7mg;
The assay of total saponins in b, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, and adding distil water makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the measuring bottle, water bath method takes out immediately, and precision adds 1%~50% vanillin-glacial acetic acid solution 0.1~10ml, perchloric acid 0.1~15ml shakes up, and heats 3~50 minutes in 30~80 ℃ of water-baths, take out, with ice-water bath or flowing water cooling, precision adds glacial acetic acid to scale immediately, shake up, as need testing solution, with the ginsenoside Rg 1Or ginsenoside Rb 1Or ginsenoside Re or ginsenoside Rf be reference substance, gets reference substance solution with legal system.With the retinue solvent is blank, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place at 547 ± 10nm measures trap, calculate with external standard method or standard curve method, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and the per unit amount contains total saponins with the ginsenoside Rg 1Or ginsenoside Rb 1Or ginsenoside Re or ginsenoside Rf's meter, must not be less than 3mg;
Total polysaccharides assay in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, and it is an amount of to add 60%~dehydrated alcohol, and supersound process makes molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and is diluted to suitable concn, shakes up, precision is measured in right amount, to tool plug test tube, adding distil water is an amount of, and it is an amount of that precision adds 1%~10% phenol solution, mixing, it is an amount of to add rapidly sulphuric acid, shakes up 30 ℃~60 ℃ water-baths 5~60 minutes, take out, with ice-water bath cooling 1~30 minute, taking out immediately, is blank with the retinue solvent, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place in 488nm ± 10 measures trap, calculates with one point external standard method or standard curve method, and compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, the per unit amount contains total polysaccharides in anhydrous glucose, must not be less than 1.6mg;
Content of paeoniflorin is measured in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds methanol or ethanol or mobile phase or water dissolution or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol or alcoholic solution with the peoniflorin reference substance are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, methanol or acetonitrile-water or 0.05%~10% glacial acetic acid aqueous solution or 0.05%~10% aqueous formic acid or 0.01%~5% phosphate aqueous solution or 0.005mol/L~2mol/L sodium dihydrogen phosphate or 0.005mol/L~2mol/L potassium dihydrogen phosphate 5%~95%: 95%~5% is a mobile phase, and the detection wavelength is 200~410nm; Calculate with one point external standard method or standard curve method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains peoniflorin must not be less than 10mg;
The assay of Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds 1%~50% sodium hydroxide and makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the tool plug test tube, put the boiling water bath hydrolysis 0.5 hour~5 hours, and took out, put to room temperature, quantitatively be transferred in the measuring bottle, swing repeatedly with methanol or mobile phase and to wash test tube wall, fixed to scale, shake up, filter with microporous filter membrane, get subsequent filtrate as need testing solution; Methanol or alcoholic solution with the benzoic acid reference substance are contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, methanol or acetonitrile-water or 0.05%~10% glacial acetic acid aqueous solution or 0.05%~10% aqueous formic acid or 0.01%~5% phosphate aqueous solution or 0.005mol/L~2mol/L sodium dihydrogen phosphate or 0.005mol/L~2mol/L potassium dihydrogen phosphate 5%~95%: 95%~5% is a mobile phase, the detection wavelength is one or several in 200~410nm wave-length coverage, and column temperature is in 20~60 ℃ of scopes; Calculate behind the content again by formula Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides content %=benzoic acid content % * 480.48/122.13 with one point external standard method or standard curve method, calculate the content of Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides must not be less than 15mg;
The assay of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, methanol or acetonitrile-water or 0.05%~5% glacial acetic acid aqueous solution or 0.02%~0.5% phosphate aqueous solution 5%~80%: 95%~20% are mobile phase, the detection wavelength is one or several in 200~410nm scope, in 20~50 ℃ of scopes of column temperature; Calculate with one point external standard method or standard curve method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains lobetyolin must not be less than 0.05mg.
7, according to the method for quality control of the described compound Chinese medicinal preparation made from Radix Ginseng or Radix Ginseng Rubra or Radix Codonopsis, Radix Paeoniae Rubra or the Radix Paeoniae Alba of claim 6, it is characterized in that: the method for testing of described compound Chinese medicinal preparation content is following one or more methods:
Ginsenoside Rg in a, the compound Chinese medicinal preparation 1, ginsenoside Rb 1, one or more assay among the ginsenoside Re:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; With the ginsenoside Rg 1, ginsenoside Rb 1, one or more reference substances among the ginsenoside Re methanol solution be contrast, adopt liquid chromatography, the chromatographic column octadecylsilane chemically bonded silica is a filler, acetonitrile-water is a mobile phase, gradient elution, solvent ratios are from 0 minute to 35 minutes, and the ratio of acetonitrile is 19%, from 35 minutes to 55 minutes, the ratio of acetonitrile rises to 29% by 19%, and from 55 minutes to 70 minutes, the ratio of acetonitrile was 29%, from 70 minutes to 100 minutes, the ratio of acetonitrile rose to 40% by 29%; Flow velocity is 1.0ml/min, detects wavelength 203nm, and column temperature is 30 ℃; Calculate with external standard method or standard curve method, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and content limit should be with the next item down or several:
(1) the per unit amount contains the ginsenoside Rg 1Limit must not be less than 1.6mg;
(2) the per unit amount limit that contains the ginsenoside Re must not be less than 0.8mg;
(3) the per unit amount contains ginsenoside Rb 1Limit must not be less than 1.0mg;
(4) the per unit amount contains the ginsenoside Rg 1, the ginsenoside Re the limit of summation must not be less than 3.4mg;
The assay of total saponins in b, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the 10ml measuring bottle, adds water to scale, shake up, precision is measured 0.6ml, to the 25ml measuring bottle, water bath method takes out immediately, and precision adds 5% vanillin-glacial acetic acid solution 0.5ml, perchloric acid 2.0ml shakes up, and heating is 15 minutes in 60 ℃ of water-baths, take out, with ice-water bath cooling 2 minutes, precision added glacial acetic acid to 25ml immediately, shake up, as need testing solution; With the ginsenoside Rg 1Be reference substance, get reference substance solution with legal system.With the retinue solvent is blank, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, measure trap, calculate with external standard method or standard curve method at the wavelength place of 547nm, compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, and the per unit amount contains total saponins with the ginsenoside Rg 1Meter must not be less than 6mg;
The assay of total polysaccharides in c, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds 80% ethanol 20ml, and supersound process makes molten loosing, centrifugal, get precipitation, adding distil water makes dissolving in right amount and is diluted to suitable concn, shakes up, precision is measured in right amount, to 10ml tool plug test tube, adding distil water is to 2ml, and precision adds 4% phenol solution 1ml, mixing, add rapidly sulphuric acid 7ml, shake up, 40 ℃ of water-baths 30 minutes, take out, with ice-water bath cooling 5 minutes, taking out immediately, is blank with the retinue solvent, adopt the disclosed spectrophotography of Chinese Pharmacopoeia appendix, wavelength place at 488nm measures trap, calculates with one point external standard method or standard curve method, and compound Chinese medicinal preparation to be measured is unit quantity to be equivalent to every day with output, the per unit amount contains total polysaccharides in anhydrous glucose, must not be less than 3.2mg;
Content of paeoniflorin is measured in d, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, adds dissolve with methanol or is diluted to suitable concn, shakes up, and filters, and gets subsequent filtrate as need testing solution; Methanol solution with the peoniflorin reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and methanol-0.1% formic acid solution was a mobile phase in 40%: 60%, and the detection wavelength is 230nm; Calculate with one point external standard method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains peoniflorin must not be less than 20mg;
The assay of Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides in e, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds 5% sodium hydroxide solution and makes dissolving and fixed to scale in right amount, shake up, precision is measured in right amount, puts in the tool plug test tube, put the boiling water bath hydrolysis 2 hours, and took out, put to room temperature, quantitatively be transferred in the 10ml measuring bottle, swing repeatedly with methanol or mobile phase and to wash test tube wall, fixed to scale, shake up, filter with microporous filter membrane, get subsequent filtrate as need testing solution; Methanol solution with the benzoic acid reference substance is contrast, adopt liquid chromatography, chromatographic column is a filler with octadecylsilane chemically bonded silica or eight alkyl silane bonded silica gels or dialkyl silane bonded silica gel, acetonitrile-0.02mol/L sodium dihydrogen phosphate was a mobile phase in 20%: 80%, the detection wavelength is 230nm, 35 ℃ of column temperatures; Calculate behind the content again by formula Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides content %=benzoic acid content % * 480.48/122.13 with one point external standard method, calculate the content of Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains Radix Paeoniae Alba total glucosides or Radix Paeoniae Rubra total glycosides must not be less than 30mg;
The assay of lobetyolin in f, the compound Chinese medicinal preparation:
It is an amount of to get compound Chinese medicinal preparation to be measured, puts in the measuring bottle, adds methanol to scale, shakes up, and filters with microporous filter membrane, gets subsequent filtrate as need testing solution; Methanol solution with lobetyolin's reference substance is contrast, adopts liquid chromatography, and the chromatographic column octadecylsilane chemically bonded silica is a filler, and acetonitrile-water is a mobile phase at 22: 78, and the detection wavelength is 267nm, 30 ℃ of column temperatures; Calculate with one point external standard method or standard curve method, each preparation is unit quantity to be equivalent to every day with output, and the limit that the per unit amount contains lobetyolin must not be less than 0.1mg.
8, according to the method for quality control of claim 6 or 7 described compound Chinese medicinal preparation, it is characterized in that: the assay result of described ejection preparation, can survey composition except that adjuvant, the ginsenoside Rg in its quality standard 1, ginsenoside Rb 1, all or part of kind in ginsenoside Re, peoniflorin, Radix Paeoniae Rubra total glycosides or Radix Paeoniae Alba total glucosides, total polysaccharides, total saponins, lobetyolin, atractylenoide etc. total content account for more than 25%.
CN 200510107818 2005-09-30 2005-09-30 Quality control of Chinese medicinal compound preparation Pending CN1939433A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510107818 CN1939433A (en) 2005-09-30 2005-09-30 Quality control of Chinese medicinal compound preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510107818 CN1939433A (en) 2005-09-30 2005-09-30 Quality control of Chinese medicinal compound preparation

Publications (1)

Publication Number Publication Date
CN1939433A true CN1939433A (en) 2007-04-04

Family

ID=37958135

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510107818 Pending CN1939433A (en) 2005-09-30 2005-09-30 Quality control of Chinese medicinal compound preparation

Country Status (1)

Country Link
CN (1) CN1939433A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102028839A (en) * 2009-09-28 2011-04-27 天津中新药业集团股份有限公司达仁堂制药厂 Quality control method of Chinese medicinal preparation for regulating menstruation in Department of Obstetrics and Gynecology
CN102890086A (en) * 2012-10-18 2013-01-23 青岛华仁药业股份有限公司 Method for determining sodium bicarbonate content in compound preparation
CN104198615A (en) * 2014-09-17 2014-12-10 上海海虹实业(集团)巢湖今辰药业有限公司 Method for determining content of paeoniflorin in flavored motherwort cream
CN107843677A (en) * 2017-12-06 2018-03-27 广州卡马生物科技有限公司 Radix paeoniae rubrathe reference extract and its preparation method and application
CN108088715A (en) * 2017-12-06 2018-05-29 广州卡马生物科技有限公司 Moutan bark reference extract and its preparation method and application
CN110196305A (en) * 2019-06-28 2019-09-03 远大医药黄石飞云制药有限公司 A kind of analysis method applied to lobetyolin's content in fertile Er'bao granule
CN110297052A (en) * 2019-07-30 2019-10-01 数源汇通(北京)医药科技有限公司 The HPLC measuring method of Radix Notoginseng content in the ruffian that disappears stomach function regulating Chinese materia medica preparation

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102028839A (en) * 2009-09-28 2011-04-27 天津中新药业集团股份有限公司达仁堂制药厂 Quality control method of Chinese medicinal preparation for regulating menstruation in Department of Obstetrics and Gynecology
CN102028839B (en) * 2009-09-28 2015-02-25 天津中新药业集团股份有限公司达仁堂制药厂 Quality control method of Chinese medicinal preparation for regulating menstruation in Department of Obstetrics and Gynecology
CN102890086A (en) * 2012-10-18 2013-01-23 青岛华仁药业股份有限公司 Method for determining sodium bicarbonate content in compound preparation
CN102890086B (en) * 2012-10-18 2014-12-24 青岛华仁药业股份有限公司 Method for determining sodium bicarbonate content in compound preparation
CN104198615A (en) * 2014-09-17 2014-12-10 上海海虹实业(集团)巢湖今辰药业有限公司 Method for determining content of paeoniflorin in flavored motherwort cream
CN107843677A (en) * 2017-12-06 2018-03-27 广州卡马生物科技有限公司 Radix paeoniae rubrathe reference extract and its preparation method and application
CN108088715A (en) * 2017-12-06 2018-05-29 广州卡马生物科技有限公司 Moutan bark reference extract and its preparation method and application
CN110196305A (en) * 2019-06-28 2019-09-03 远大医药黄石飞云制药有限公司 A kind of analysis method applied to lobetyolin's content in fertile Er'bao granule
CN110297052A (en) * 2019-07-30 2019-10-01 数源汇通(北京)医药科技有限公司 The HPLC measuring method of Radix Notoginseng content in the ruffian that disappears stomach function regulating Chinese materia medica preparation

Similar Documents

Publication Publication Date Title
CN1836717A (en) Quality controlling method for pulse restoring injection
CN1689636A (en) Quality controlling method for traditional Chinese medicine injection made from radix salvia miltiorrhiza and safflower
CN1853673A (en) Quality controlling method of double-Danshen injection
CN1939461A (en) Quality control of Chinese medicinal compound preparation
CN1939433A (en) Quality control of Chinese medicinal compound preparation
CN1876022A (en) Pharmaceutical composition with red sage root and Erigeron breviscapus for treating cerebrovascular disease, its preparation process and quality control method
CN101036774A (en) Quality control method of compound cantharidin oral preparations
CN101062294A (en) Method for detecting the quality of the medicine combination for treating cerebral apoplexy and vasculitis
CN1911395A (en) Method for controlling quality of injection contg. traditional Chinese medicine
CN1785263A (en) Quality control method of compound polygonium oriental preparation
CN1954868A (en) Yinju Qingyan Preparation for treating disease by flaring-up of fire of deficiency type and preparation method and quality control method
CN1958003A (en) Preparation for treating chronic nasosinusitis, preparation method and quality control method
CN1772013A (en) Quality control method for ginkgo-dipyridamine injection
CN1876039A (en) Pharmaceutical composition for treating upper respiratory tract infection, its preparation process and quality control method
CN1911393A (en) Injection contg. traditional Chinese medicine, and its quality control method
CN1600365A (en) Method for controlling quality of tonic semifluid extract of ten ingredients
CN1876028A (en) Pharmaceutical preparation for treating coronary heart disease, its preparation process and quality control method
CN1939371A (en) Quality control of Chinese-medicinal compound preparation
CN1939391A (en) Quality control of Chinese-medicine compound preparation
CN1616014A (en) Chinese medicine composition for treating diabetes and its preparing method
CN1939472A (en) Quality control of compound preparation for treating diabetes
CN1156487C (en) Phenylethanol boschnaloside compounds
CN1853674A (en) Quality controlling method of Xingdan injection
CN1911394A (en) Method for controlling quality of injection contg. traditional Chinese medicine
CN1939368A (en) Quality control of Chinese medicinal compound preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication